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INTRO Instrument Assisted Soft Tissue Mobilization (IASTM) is a popular treatment technique to 
reduce pain, help improve functional range of motion, and corresponding functional task 
completion. It has been reported both anecdotally and through controlled-clinical trials to 
evoke acute changes in skeletal muscle physiology through a variety of proposed mechanisms. 
However, the efficacy of IASTM has been called into question particularly as it pertains to its 
ability to improve skeletal muscle and connective tissue pathologies relative to traditional 
therapies including: stretching, light exercise, and therapeutic ultrasound. The purpose of this 
three-study investigation was to elucidate the effects of IASTM on human skeletal muscle as 
well as to examine possible mechanisms of change.  METHODS To examine the efficacy of 
IASTM we designed three experiments. The first experiment tests the effects of IASTM on IL-6 
and TNF-α cytokine expression in human skeletal muscle using Bergstrom needle muscle 
biopsies. Pro-inflammatory cytokines were of interest as they have been suggested to mediate 
positive outcome measures associated with IASTM. The second investigation was designed to 
examine the dose response in the presence of two different forces being administered. This 
study was largely designed as a follow up of an IASTM dose response experiment that was 
carried out in rodents. The final investigation was designed to examine the effects of IASTM on 
the architecture of skeletal muscle using diagnostic ultrasound. For this investigation both 
hamstrings range of motion restricted and age appropriate controls were used to examine if 
IASTM only elicits benefit in pathological tissue. RESULTS Results from this multi-study 
examination of the effects of IASTM have suggested that IASTM may not be the most 
αefficacious treatment available for degenerate soft-tissue. Our three investigations found no 
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changes in MTS, PROM, MVC-PT, myokine expression, perception of functional ability as 
measured by the PFAQ, muscle quality (echo intensity), pennation angle or hip ROM.  
DISCUSSION The results from these three investigations suggest IASTM may not be efficacious 
especially when compared to more cost effective self-therapies including stretching and light 
exercise. However, the current investigations at hand were limited by sample size and the fact 
that two of the investigations were carried out in non-pathological tissue. Literature review 
reveals that IASTM can elicit change in degenerate muscle tissue through a fibroblast mediated 
pathway. Future investigations should use larger sample sizes and special populations including 
older adults and adults suffering from chronic tendinopathy.  
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Chapter 1: Introduction 
 Injury to human skeletal muscle tissue is a common occurrence and is caused by a 
variety of mechanisms. Soft tissue pain and corresponding loss of function often lead to missed 
work, sports participation, and other lifestyle disturbances. For this reason, it is vital to 
understand the pathophysiology of injured skeletal muscle and connective tissue as well as the 
mechanisms by which healing can best be facilitated.   
 It is generally believed that multiple pathophysiological factors are at play in acute or 
chronically damaged skeletal muscle. First, in instances of muscle damage there is the presence 
of over-stretched sarcomeres within the myo-fibril structure. Second, there appears to be 
damage to the excitation coupling system. It remains controversial, which of these two 
phenomena represents the point of primary damage. Some researchers believe that excessive 
sarcomeric stretching is the primary cause of loss of function, still others have declared that 
decreased passive muscle tension and other markers of dysfunction following muscle damage is 
caused by disturbance of the excitation-contraction coupling system. In addition to sarcomeres 
being stretched and disruption of the excitation-contraction, coupling system it has also been 
hypothesized that muscle damage entails micro-tears to the contractile proteins of the 
sarcomere. Damage to actin, myosin, titin, or any of the proteins associated with the 
sarcomeric scaffolding could obviously disturb normal physiological function. With these three 
pathophysiological considerations, it is logical that the aim of post injury rehabilitation should 
be to return sarcomeres to normal, resting length, to return excitation-contraction coupling to 
normalcy and to initiate skeletal muscle protein synthesis. These outcome measures all require 
muscle biopsy and subsequent molecular biology experimentation to observe but in-vivo 
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derivatives of these do exist and would include variables associated with whole muscle force 
production. 
 Due to the fact that skeletal muscle injury is a leading cause of missed work. For this 
reason, the health sciences community is perpetually developing and evaluating new 
techniques designed to aid in expedited return of function and decreased pain perception. 
Traditionally these rehabilitation efforts are broken up into two broad subcategories. First, 
there is the acute injury phase of treatment where the general focus of treatment is to 
decrease pain, swelling and inflammation. This is generally carried out by rest, cryotherapy, 
compression, elevation of the injured region and pharmacological interventions. These 
pharmacological treatment regimens generally include the use of non-steroidal ant-
inflammatory medications (NSAID’s) and occasionally opiates depending on the level of 
perceived pain.  
 The second general phase of rehabilitation begins when signs of acute injury are 
diminishing or have completely passed. During this phase of rehabilitation the general 
treatment goal is to return the affected region to its normal, pre-injury functional ability when 
possible or to minimize permanent loss of function. This includes therapy techniques and 
corrective exercises centered on increasing muscular strength, increasing muscular endurance 
increasing range of motion. At this stage in recovery techniques like instrument assisted soft 
tissue mobilization (IASTM) are often used. IASTM is an umbrella term for techniques that 
feature clinicians using specialized instruments to mechanically load degenerate soft tissue in a 
massage like manner. 
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 It has been reported both anecdotally and through a small body of controlled, clinical 
trials that IASTM alters the chemistry of soft tissue. However, it is unclear which recovery 
signaling pathways IASTM is capable of initiating as well as whether or not IASTM can alter pro-
inflammatory signaling. Further, there is controversy as to whether or not altering the body’s 
natural inflammation pathways is beneficial or deleterious to long term growth and repair. 
More controlled, clinical trials are needed to address these research questions. 
Mechanical loading of soft tissue whether by injury, massage or IASTM affects the 
extracellular matrix (ECM) of skeletal muscle. This phenomena is most simply demonstrated by 
coordinated ECM fibroblast proliferation. Fibroblasts are specialized cells that are present in the 
extracellular matrix of skeletal muscle as well as other cells. Skeletal muscle fibroblasts that 
become mechanically stimulated produce vital structural proteins including collagen and elastin 
as well as signaling molecules including cytokines and growth factors. It has been demonstrated 
that IASTM can cause up-regulated fibroblastic activity. Both injury and IASTM increase the 
number of fibroblasts in skeletal muscle fascia leading to downstream signaling cascade 
activation. In cases of acute injury up-regulated pro-inflammatory cytokine expression has been 
observed. The downstream signaling effects of IASTM are less clear. It has been hypothesized 
that IASTM initiates similar signaling cascades to that of an acute injury just on a smaller, more 
beneficial scale. However, it has also been hypothesized that IASTM causes anti-inflammatory 
signaling following injury. These theories are apparently contradictory and though many 
clinicians have found IASTM treatments efficacious the exact mechanism by which positive 
outcome measures have been observed is poorly understood.  
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To this end we found it prudent that our first study examine how IASTM effects whole 
muscle performance as well as cytokine expression. We believed that by procuring –pre and –
post IASTM muscle biopsies we could determine if benefits reported concerning IASTM are 
initiated via a cytokine mediated pathway. Upon completion of this study we saw that a 
possible confounding component of our study design and most study designs in the literature is 
that there are currently no research groups quantifying or controlling IASTM pressure volume 
administered to human subjects. Further, no researchers were exploring IASTM dosage 
parameters in human subjects. Upon completion of this study we determined to begin working 
in populations in which IASTM is clinically indicated. In order to carry this out we found it more 
prudent to recruit subjects with existing loss of muscle function rather than inducing it through 




1.1 Study 1- IASTM and Cytokine IL-6 signaling 
Prior to investigating the effects of IASTM on muscle damage or other chronic 
pathologies we found it prudent to study the effects of IASTM in healthy tissue. To carry this 
out we used a repeated measures study with a within subject control. In addition to measuring 
both active neuromuscular and strength properties, biopsies were taken to examine pro-
inflammatory signaling.  
First, this allowed us to make sure our treatment wasn’t detrimental to skeletal muscle 
tissue prior to investigations in populations that are already suffering from chronic or acute loss 
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of function. Secondly, this allowed us to see if IASTM evokes physiological changes through 
cytokine mediated pathways. Of particular interest was Interleukin 6 (IL-6) as it is commonly 
studied in rehabilitation sciences research due to its pro-inflammatory signaling properties. We 
found it vital to study the effects of IASTM on cytokine expression as it has been proposed that 
IASTM may cause benefit by evoking beneficial inflammation. Upon completion of this study it 
became evident to us that proper control and study of dosage parameters was a common gap 
in the literature that needed to be addressed. 
 
1.2 Study 2- IASTM Graded Pressure 
Further complicating the questions surrounding the mechanism by which IASTM 
treatments allegedly improve skeletal muscle function is the inexact nature of current dosage 
parameters. As previously described, IASTM is an umbrella term for a wide variety of 
treatments that mechanically load skeletal muscle using instrumentation. These treatments are 
generally carried out by certified athletic trainers or licensed physical therapists. Generally 
speaking, clinicians abide my manufacturer instructions concerning dosage parameters for 
treating a given injury. Most IASTM tooling manufacturers have their own protocol 
recommendations depending on intended use. Even if frequency of treatment and volume 
dosage parameters are followed by the clinician there isn’t currently a way for clinicians to 
know how much pressure is being applied to the affected area. For this reason, if there is a 
dose/response relationship between IASTM and positive outcome measures it is entirely 
possible that some clinicians are within the optimal dosage parameters while others could be 
causing sub-optimal healing or even evoking deleterious results. 
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Further, inexact dosage parameters make comparison of one research study to the next 
difficult. Though controlled clinical trials featuring IASTM usually do report IASTM dosages used 
in-vivo, many of the research papers published by clinicians do not. Unfortunately, most of the 
studies that have controlled for or at minimum quantified pressure forces during IASTM 
treatments have occurred in in-vivo rodent models. While these rodent models are highly 
controlled and IASTM dosages are precisely administered the carry over between rodents and 
humans will always be questioned.  
Not until recently has a research cohort attempted to quantify pressure forces 
administered during an in-vivo IASTM controlled trial. This tooling developed at the University 
of Kansas is essentially a retro-fitting in line, load cell device that could potentially integrate 
with most commercially available IASTM tools. This development should set the bar as far as 
what is expected of laboratory methods for lab groups who wish to publish in-vivo IASTM 
controlled.  Upon completion of this paper it became evident that we needed to begin clinical 
trials in special populations including those who have chronic musculo-skeletal restrictions.  
 
1.3 Study 3- IASTM as a Treatment for ROM Restriction 
Another common application of IASTM can be observed in ROM restricted populations. 
ROM restriction is generally caused and perpetuated by sedentary living. The traditional 
treatment for such conditions is increased activity and possibly a stretching program. While this 
decreased muscular pliability may initially appear innocuous it is highly correlated with and 
potentially the cause of many forms of chronic pain including low back and joint pain.  
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It remains unclear if IASTM or even massage alter range of motion in acute applications. 
For this reason it is vital that acute study designs be utilized. Further, in addition to tracking 
changes in ROM caused by IASTM it is vital that muscle-tendon stiffness properties, muscle 
length and pennation angle data be collected to speak to possible mechanisms of change. It is 
for this reason that our most recent investigation examined markers of skeletal pliability using 




Chapter 2: Literature Review 
 
2.1 Introduction:  
 Instrument assisted soft tissue mobilization (IASTM) is a technique commonly used in 
the field of physical therapy and is generally carried out by using metal or plastic tools with 
smooth edges to mechanically compress the affected muscle and tendon in a massage-like 
motion (Hammer, 2008). IASTM is clinically indicated when muscular adhesions and scar tissue 
lead to restricted range of motion. Irrespective of its popularity, the efficacy IASTM has largely 
been supported by anecdotal findings rather than through controlled research. Further, most 
published research featuring human subject model designs are case studies written by clinicians 
in the field. Thus, it is difficult to draw application from these models because they are purely 
observational.  
          The alleged benefits of IASTM range from increased blood flow, increased venous return, 
decreased cortisol production and increased ROM due to decreased scar tissue (Hammer, 
2008). Unfortunately, the small body of literature that does exist in human skeletal muscle do 
not explore mechanism(s) of change. The few randomized, controlled, clinical trials that do exist 
are generally featuring animal models that explore the mechanism of change, but are not 
necessarily directly translational. For this reason. It is difficult to draw conclusions concerning 







2.2 Origins of IASTM 
In ancient Greece and Rome, the use of small, curved metal tools known as strigils were 
used to scrape dirt and sweat from the body but anecdotally helped with generalized muscle 
soreness as well (Hammer, 2008). Similarly, Gua Sha a healing technique that originated in Asia 
was being developed around the same time (Braun et al., 2011; Hammer, 2008; Lee, Choi, Kim, 
& Choi, 2010). Gua Sha was generally carried out by use of animal bone and horns for 
instrumentation (Braun et al., 2011; Lee et al., 2010). Despite the fact that IASTM has been 
around since ancient civilizations, it is still unclear if measurable benefit is derived from IASTM 
treatment. Further, the mechanism by which IASTM changes the physical and chemical 
properties of human skeletal muscle is unknown. IASTM is a technique that was invented based 
on the anecdotal benefits of massage therapy. However, further research is needed to explore 
IASTM and its effect on human skeletal muscle. 
Instrument assisted soft tissue mobilization uses specifically designed solid instruments 
that are generally made out of aluminum alloys. These instruments are often preferred because 
they allow for more pressure to be applied for longer periods of time without the clinician 
becoming fatigued. This is particularly helpful in the treatment of tendinopathy as many 
tendons are difficult to manually palpate. It has been anecdotally reported that IASTM 
ultimately allows the clinician to cause micro-trauma in a more precise and localized fashion 
when compared with manual massage. It is generally believed that this micro trauma initiates 
Type-1 collagen synthesis and re-alignment via a prostaglandin mediated pathway (Langberg et 




2.3 Effects of Soft Tissue Mobilization on Whole Muscle Physiology 
2.3.1 Soft Tissue Mobilization and joint ROM 
 One of the most often proposed benefit of soft tissue mobilization is that it has the 
ability to increase ROM of affected joints. Passive range of motion has been defined as the 
range of motion available to a joint or series of joints (Gleim & McHugh, 1997) and is usually 
measured manually with a goniometer. The majority of studies that have analyzed the effects 
of soft tissue mobilization on muscle and connective tissue have been based on range of 
motion measurement as a primary outcome measure (Crosman, Chateauvert, & Weisberg, 
1984; Hernandez-Reif, Field, Krasnegor, & Theakston, 2001; Huang et al., 2010; Leivadi et al., 
1999; Morien, Garrison, & Smith, 2008; Nordschow & Bierman, 1962; Wiktorsson-Moller, 
Öberg, Ekstrand, & Gillquist, 1983). These studies suggest that soft tissue mobilization like 
massage and IASTM may be beneficial for increasing joint ROM (Crosman et al., 1984; Diana 
Hopper et al., 2005; D Hopper et al., 2005; Huang et al., 2010; Leivadi et al., 1999; Morien et al., 
2008). For example, one study found an increased joint angle and no associated increase in 
passive tension or EMG following massage (Huang et al., 2010). This is an interesting finding as 
it has been hypothesized that at least a portion of the increased ROM comes from neural 
responses. It was suggested that modified stretch perception, increased stretch tolerance, or 
increased compliance of the hamstrings as possible mechanisms for this observed increase in 
joint ROM (Huang et al., 2010). Unfortunately, Huang et al. and most of the other papers at 
hand didn’t propose a definitive hypotheses in regards to the mechanism of ROM change. 
 Still other studies have shown conflicting data demonstrating that massage and 
potentially other forms of soft tissue mobilization may not effect ROM (Barlow et al., 2004; 
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Hilbert, Sforzo, & Swensen, 2003; Jourkesh, 2007; Vardiman et al., 2015). For example, previous 
reports have suggested that 15 minutes of massage elicit no significant ROM changes in 
adolescent soccer players (Jourkesh, 2007), or active adults (Barlow et al., 2004). Regardless of 
the efficacy of clinician mediated soft tissue mobilization to increase ROM, it unlikely to rival 
more traditional treatments if ROM restricted patients are able to improve ROM through the 
use of cheaper modalities like stretching and self-myofascial release. 
When the effects of massage on lower extremity range of motion were compared with 
other pre-exercise modalities such as dynamic warm-up and stretching, massage increased only 
ankle dorsiflexion range of motion while stretching significantly increased all lower extremity 
range of motion measurements (Wiktorsson-Moller et al., 1983). Thus, the practicality of 
clinician directed soft tissue mobilization has been called into question due to the superior 
efficacy and cost effectiveness of stretching. 
 
2.3.2 Efficacy of IASTM in treatment of muscle damage 
In addition to increasing joint ROM, it has been hypothesized that IASTM may be 
beneficial in the treatment of post exercise muscle damage. One of the most prolific research 
cohorts on the topic at hand have devised a protocol for testing soft tissue mobilization in 
rabbit tibialis anterior (Butterfield, Zhao, Agarwal, Haq, & Best, 2008; Crawford et al., 2014; 
Haas, Best, Wang, Butterfield, & Zhao, 2012; Haas et al., 2013; Waters-Banker, Butterfield, & 
Dupont-Versteegden, 2014). One research group has set out to answer multiple research 
questions including how IASTM effects muscle recovery following bouts of intense eccentric 
exercise (Butterfield et al., 2008).  The in vivo animal model allows the researchers to induce 
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muscle damage through an eccentric loading protocol while the rabbit is anesthetized. While 
anesthetized, the tibialis anterior is maximally stimulated by a surgically implanted stimulator 
while the muscle is being stretched through the ankle joints ROM effectively causing repeated 
maximal eccentric contractions (Crawford et al., 2014).  
Butterfield et al. have used eccentric loading prior to IASTM and massage treatments in 
order to evoke muscle soreness/damage as massage and IASTM have both been indicated in 
such cases. They found that 30 minutes of cyclic compressive loading of the tibialis anterior has 
the ability to improve skeletal muscle recovery following a bout of eccentric exercise 
(Butterfield et al., 2008).  Animals who received soft tissue mobilization demonstrated 
statistically significant increases in recovery of peak torque following muscle damage as well as 
decreased leukocyte infiltration (Butterfield et al., 2008).  
 
 2.3.3 Pathophysiology of Skeletal Muscle Damage 
In order to fully understand the efficacy of IASTM to treat muscle damage one must first 
understand the pathophysiology of injured skeletal muscle. It is generally agreed upon that in 
all forms of skeletal muscle damage there are at least three prominent common pieces of 
cellular and subcellular dysfunction present. First, there is the presence of elongated and 
otherwise disrupted sarcomeres within the myofibrils. Second, muscle damage causes 
disruption in the excitation-contraction coupling system within the sarcomere. Third, there is 
damage to contractile proteins as well as cytoskeletal elements of the myofibril. It’s is 
controversial which of these represents the primary event in muscle damage with several 
authors believing sarcomeric deformation is the primary event (Morgan & Allen, 1999; Proske & 
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Morgan, 2001) and at least one author believing that 75% or more of the decline in normal 
physiological contractile properties of muscle come from disruption to the excitation-
contraction coupling system (Warren, Ingalls, Lowe, & Armstrong, 2001). Still some research 
suggests that loss of function following muscle damage may be caused primarily by damage to 
cytoskeletal elements of the myofibril  Warren et al. rounds out his excitation-contraction 
coupling theory by suggesting that the remaining loss of function seen for 24-72 hours post 
injury is caused by damage to the tension bearing elements within the muscle (Warren et al., 
2001). These include the contractile proteins actin and myosin as well as the cytoskeletal 
proteins.   
 
2.3.4 The Role of Excitation-Contraction Coupling in Muscle Damage Induced Loss of 
Function 
Evidence that much of the physiological deficit caused by muscle damage stems from 
damage to the excitation-contraction coupling system stems from observational studies that 
have occurred in rodent muscle tissue. For example, it has been demonstrated that the deficit 
in passive tension of skeletal muscle caused by muscle damage can be partially recovered with 
caffeine supplementation (Balnave & Allen, 1995; Warren et al., 1993). Caffeine does not alter 
sarcomere length or cytoskeletal elements but it has been suggested that it may have the 
ability to alter excitation-contraction coupling (Balnave & Allen, 1995; Warren et al., 1993). This 
hypothesis has been tested experimentally. In the first of these studies passive muscle tension 
was nearly completely recovered by introduction of a 50 mm caffeine solution. The proposed 
mechanism by which caffeine alters resting muscle tension is through a Ca2+ dependent 
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pathway. Caffeine which causes release of Ca2+ from the sarcoplasmic reticulum and eventually 
leads to altered excitation contraction coupling in skeletal muscle. In the second, 10 mm 
caffeine was used to potentiate tension in single fibers in response to direct electrical 
stimulation. It was concluded that in mouse fibers changes in E-C coupling may be a major 
contributor to the observed fall in tension after eccentric contraction induced muscle damage 
(Allen, 2001). 
 
2.3.5 The Roll of Cytoskeletal Scaffolding Damage in Muscle Damage Induced Loss of 
Function 
Cytoskeletal scaffolding proteins including titin, nebulin, and dystrophin form a complex 
structure that anchors the sarcomere within the myofibril and allow for transmission of force. 
The sarcomeric structure exists in such a way that transmission of contractile forces laterally 
across the fiber as well as from fiber to fiber takes place (Banus & Zetlin, 1938; Ramsey & 
Street, 1940). It is therefore a logical assertion that damage to this cytoskeletal scaffolding 
could lead to alterations in whole-muscle contractile properties and subsequently lead to 
lifestyle disturbances. It has been well documented that muscle damage effects these 
cytoskeletal proteins (Friden & Lieber, 2001; Lieber & Fridén, 1999; Lieber, Woodburn, & 
Friden, 1991). Lieber and Friden have demonstrated by way of biopsies and histochemical 
preparations that eccentric exercise induced muscle damage disturbances in desmin can be 
observed as little as 5 minutes most damage. Other research has shown that cytoskeletal 
scaffolding damage continues long after the initial muscle damage invoking event (Allen, 2001). 
This has lead researchers to the following hypothesis concerning damage of cytoskeletal 
15 
 
proteins (Lieber & Fridén, 1999). First, as previously described, overextended sarcomeres cause 
a highly localized increased release of [Ca2+]. Next, elevated [Ca2+] causes activation of myo-
cellular proteases such as calpain which hydrolyses desmin; (iii) this loss of the structural 
support of desmin plays a large role in debilitating the rest of the sarcomeric scaffolding. Critics 
of this hypothesis will quickly cite the observation that markers of muscle damage can be seen 
immediately following a single very large stretch (Brooks, Zerba, & Faulkner, 1995). The fact 
that markers of cytoskeletal element muscle damage can be seen so quickly make it unlikely to 
be caused by a calcium initiated proteolytic pathway (Brooks et al., 1995). It has been 
hypothesized that the damage to cytoskeletal scaffolding following muscle damage is 
overstated because of in-precise measurement techniques (Allen, 2001). It is entirely plausible 
that when cytoskeletal proteins become stretched (through muscle damage) the 
conformational change alters antibody binding chemistry. This theory gains particular traction 
in light of the observation that titin staining increases following muscle damage (Allen, 2001). 
Whether or not there is a functional reason for this or if this is simply due to an alteration in 
binding chemistry is unclear (Lieber, Thornell, & Friden, 1996) 
 
2.3.6 Immediate vs Delayed IASTM in Treatment of Muscle Damage 
Another valuable question the Ohio State group has set out to answer centers around 
the timing of soft tissue mobilization treatments. Though soft tissue mobilization is generally 
accepted as beneficial following muscle damage, it is less clear whether the treatments should 
come immediately following the muscle damage inducing exercise or if it should be delayed. In 
order to test this research question the previously described vivo animal model was utilized. 
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This allowed the researchers to induce muscle damage through an eccentric loading in a 
controlled and measurable manner (Crawford et al., 2014).  
The researchers hypothesized that soft tissue mobilization when performed at an 
optimal magnitude, duration and loading frequency following an intense bout of eccentric 
exercise would lead to both acute (daily) and cumulative (over four-day treatment) changes in 
the muscle’s viscoelastic properties, in particular a reduction of both the instantaneous elastic 
response and apparent viscosity of the tissue (Crawford et al., 2014). Researchers found that 
the prescribed eccentric exercise protocol increased instantaneous elastic response (AG0) a 
variable commonly associated with muscle stiffness in all groups (P < 0.05). The same load 
cell/strain gauge apparatus that was used to control the pressure of the IASTM during the 
treatment was used to measure AG0 in in vivo. This served to validate that the Ohio State 
groups’ eccentric muscle damage protocol was effective in altering the whole muscle 
physiology of the TA. Recovery of AG0 was not significant in the immediate or delayed group 
compared to the control group following four days of massage. However, within-day (pre/post 
massage) analysis revealed a significant decrease in AG0 in both massage groups. These findings 
suggest that soft tissue mobilization following eccentric exercise has a greater effect on 
reducing muscle stiffness, estimated by AG0, within-day rather than affecting recovery over 
multiple days. Further, these data suggest that soft tissue mobilization immediately following 






2.3.7 IASTM and Muscle/Tendon Stiffness in Humans In-Vivo 
As just described, one proposed benefit of IASTM is that it decreases muscle/tendon 
stiffness. However, only two in-vivo human model studies have examined the effects of 
massage/soft tissue mobilization on passive muscle/tendon stiffness. In one study a 10-minute 
effleurage massage had no significant effects on passive gastrocnemius stiffness properties 
when compared with 10-minutes of rest (Stanley, Purdam, Bond, & McNair, 2001). Authors of 
this study cited that the pressure of the effleurage treatment administered by the clinician may 
not have been enough to elicit a physiological response. 
In another study IASTM was used to explore the effect of soft tissue mobilization on 
passive muscle/tendon stiffness of that plantar flexors (Vardiman et al., 2015). Results from this 
study indicated that IASTM, when performed at standard clinical pressures, did not alter 
passive muscle/tendon stiffness of the plantar flexors in healthy, college aged participants. 
Further research is needed to investigate the effects of other soft tissue mobilization 
techniques.  
 
2.3.8 Soft Tissue Mobilization and Blood Flow 
Another proposed benefit of massage is an increase in blood flow. Although anecdotally 
authors have agreed that massage could increase blood flow, study results have been 
inconclusive largely because of research study design limitations. Besides having a small sample 
size (Bell, 1964; Dubrovsky, 1983; Hansen & Kristensen, 1973) most of these studies had no 
reported statistical analysis, (Bell, 1964; Dubrovsky, 1983; Hansen & Kristensen, 1973)  nor did 
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they use a control group , (Bell, 1964; Dubrovsky, 1983; Hansen & Kristensen, 1973). These 
limitations make it hard to differentiate the changes in blood flow from normal variation. More 
importantly, the venous occlusion plethysmograph and Xenon wash-out techniques used in 
these studies have their own limitations.  
Venous occlusion plethysmograph generally demonstrates underestimation of blood 
flow due to the inflation of the cuff extreme sensitivity to movement artifacts (Shoemaker, 
Tiidus, & Mader, 1997; P. Tiidus & Shoemaker, 1995). At times the changes of blood flow could 
not be expressed quantitatively because of these limitations (Hansen & Kristensen, 1973). 
Moreover, venous occlusion plethysmography cannot be used to measure blood flow during 
massage but only immediately following the treatment (P. Tiidus & Shoemaker, 1995). Further, 
the Xenon wash-out technique overestimated blood flow because of the local trauma from 
injection of the tracer (Shoemaker et al., 1997; P. Tiidus & Shoemaker, 1995; P. M. Tiidus, 
1999). Pulsed Doppler ultrasound has been used to investigate muscle blood flow and has 
indicated that manual massage did not affect blood flow in the muscle after treatment of the 
muscle (Shoemaker et al., 1997; P. Tiidus & Shoemaker, 1995). However, the ultrasound used in 
these studies detected changes in the large artery and vein but did not detect microcirculation 
in muscle that could be affected by massage. Because pulsed Doppler ultrasound can only 
examine major blood supply it is difficult to draw any conclusion about whether or not soft 
tissue mobilization causes increased microcirculation the affected region.  
In addition to localized changes in blood flow, it now appears soft tissue mobilization 
techniques may lead to alterations in systemic blood flow (Franklin, Ali, Robinson, Norkeviciute, 
& Phillips, 2014). Previous research shows that flow-mediated dilation (FMD), the “gold 
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standard” in-vivo measure of endothelial function, is impaired in healthy but sedentary young 
adults after an acute bout of strenuous lower extremity resistance exercise involving both 
eccentric and concentric muscle contractions (Phillips, Das, Wang, Pritchard, & Gutterman, 
2011). Franklin et al. set out to explore if this decreased FMD could be attenuated by soft tissue 
mobilization and the found that it can be (Franklin et al., 2014). In that study, a single lower 
extremity soft tissue mobilization treatment resulted in the elevation of brachial artery FMD 
that lasted for 48 hours after exertion-induced muscle injury. This treatment also increased 
FMD in the absence of exercise (Franklin et al., 2014). These results indicate that soft tissue 
mobilization may have the ability to improve blood flow, particularly at the macro circulatory 
level. 
 
2.4 Cellular and Sub-Cellular Effects of IASTM 
2.4.1 The Role of Fibroblasts in IASTM Mechano-Transduction 
Musculo-tendinous tissue that is compressed by IASTM undergo histochemical 
modifications that lead to a host of downstream signaling cascades. These downstream 
signaling cascades are apparently mediated by fibroblast proliferation but the exact 
mechanotransduction pathway is not fully understood. Musculo-tendinous fibroblast have a 
number of structural characteristics that make them unique in addition to their ability to 
produce molecules necessary for muscle and tendon cell structure. Musculo-tendinous 
fibroblasts are easily identified by their flattened, elongated shape as well as long there 
elongated nuclei and actin-based cytoplasmic protrusions (Kjær et al., 2009). Tendinous 
fibroblasts interact with the extra cellular matrix (ECM) by way of an advanced coupling 
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network that is often referred to as “collagen cross linking” (Kjær et al., 2009). As previously 
mentioned the exact mechano-transduction pathway by which soft tissue mobilization initiates 
molecular signaling is not fully understood but it is believed to be initiated by structural 
proteins located in the extra cellular matrix (ECM) of muscle. 
 
2.4.2 Role of Fibroblast in Growth and Repair  
Musculotendinous repair occurs in a three step process: inflammation, proliferation, 
and remodeling. During the acute inflammatory stage, blood platelets and fibrin cover the 
musculotendinous wound and fibroblasts and phagocytic cells translocate to the site of soft 
tissue injury. The fibroblasts begin to produce fibronectin. In the proliferative stage, fibroblasts 
increase in number and begin synthesizing Type III collagen. The remodeling or maturation 
stage involves a reduction in cellularity and realignment of collagen fibers. Also collagen 
production shifts from immature, Type III collagen, to mature, Type I collagen, and fibronectin 
production decreases (Davidson et al., 1997).  
Perhaps the most explored aspect of the effect of IASTM on human skeletal muscle is 
the dose/response relationship that appears to be present. In the late nineties, research 
exploring the effect of various pressure loads on skeletal muscle fibroblast proliferation in rat 
hind-limb tissue was published out of Ball State University (Gehlsen, Ganion, & Helfst, 1999). 
Gehlsen et al. utilized a popular tendinopathy induction model in which unilateral tendinopathy 




2.4.3 Tendinopathy and IASTM Animal Model 
In order to examine the effect of IASTM on tendinopathy a common in vivo animal 
model was utilized. Collagenase injections were administered directly into the achilles tendon of 
rabbits to induce achilles tendinopathy. This research was novel not only in the sense that the 
relationship between the mechanical loading of skeletal muscle fibroblast proliferation had 
never been explored but also in the sense that there were three different pressure groups 
allowing researchers to explore interaction effects (Gehlsen et al., 1999). These pressure groups 
were designated: light IASTM (.5 N/𝑚𝑚𝑚𝑚2), medium IASTM (1.0 N/𝑚𝑚𝑚𝑚2) and extreme IASTM 
(1.5 N/𝑚𝑚𝑚𝑚2). The only group that was statistically significant from the rest in terms of fibroblast 
activation was the Achilles compromised “extreme IASTM” group. This suggest not only that 
IASTM benefits appear to be dose dependent but also that unless the high pressure is 
administered to damaged tissue there may not be any biological effect.  
  
2.4.4 Development of an In-Vivo Human Pressure Quantification Tooling  
When studying the effects of IASTM it is vital that IASTM pressure administration 
volumes be reported. This is due to the fact that many of these molecular signaling responses 
appear to be dose dependent. However, until recently there has been no device capable of 
quantifying IASTM pressure administration during in-vivo human trials. This is a gap in the 
literature. In animal models the relationship between IASTM and tissue response has been 
shown to be dose dependent in regards to load administered (Gehlsen et al., 1999). Presumably 
the response to IASTM is dose dependent in humans as well.  This dose dependency was first 
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demonstrated in a fibroblast proliferation model (Gehlsen et al., 1999) however it appears to be 
present in other variables of interest as well. For example, in addition to fibroblast response 
being dose dependent, it appears the relationship between mechanical loading of soft tissue, 
ion kinetics (McNamee, Ingber, & Schwartz, 1993), protein synthesis (Thie, Schlumberger, 
Rauterberg, & Robenek, 1989), gene expression (Komuro et al., 1991) and release of secondary 
signaling proteins (Letsou, Rosales, Maitz, Vogt, & Sumpio, 1989) are dose dependent as well. 
Pilot data generated in our lab suggest that the IASTM pressure forces administered by 
experienced clinicians is considerably less than the pressure forces used in the animal models 
(Table 1). In addition to the differences in mean pressure forces applied, the animal models 
differ in total IASTM volume. The most commonly used IASTM volume prescription in the 
animal model literature is 3 proximal to distal strokes and 3 distal to proximal strokes (Gehlsen 
et al., 1999). Generally IASTM treatments in humans utilize substantially more volume and 
lower pressure. For this reason it is vital that researchers keep soft tissue mobilization dosage 
parameters in mind when interpreting results. Differences in outcomes could theoretically be 




Table 1: Dosage Parameters: Comparison of clinical animal/human model pressure 
administration 
Author, Year Model Summary Pressure Force  Administered Outcome 
(Gehlsen et al., 1999) Collagenase induced 
Achilles tendonitis rat 
model (n=30) 
Light IASTM= (.5 N/𝑚𝑚𝑚𝑚2) 
Medium IASTM= (1 N/𝑚𝑚𝑚𝑚2) 





(M. T. Loghmani & 
Warden, 2009) 
Bilateral torn MCL rat 
model (n=51) 






(M. Loghmani & 
Warden, 2013) 
Bilateral torn MCL rat 
model (n=30) 




(Davidson et al., 
1997) 
Collagenase induced 
achilles tendonitis rat 
model (n=20) 




(Vardiman et al., 
2015) 
Human Subjects, 
controlled trial (n=11) 
N/𝑚𝑚𝑚𝑚2 equivalent is estimated 
at 1.0 
No changes in 
ROM or IL-6 
expression 
(p<.05) 
Ohio State Group Rabbit tibialis 
anterior, eccentric 
loading (n= varies 












2.4.5 IASTM’s effect on Collagen Synthesis  
A common anecdotal report is that IASTM helps “realign” connective tissue. This 
ambiguous, anecdotal report is yet to be studied in conjunction with IASTM but there is a body 
of research that appears to be directly translational to IASTM treatments. The overall 
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contribution of collagen to whole body protein turnover is unknown, despite the fact that 
collagen probably contributes 3.5 kg to the lean body mass compared with 12 kg for muscle 
myo-cellular protein, about which much more is known (Langberg et al., 2007). Regardless of its 
comparative contribution to total organismal mass it is functionally vital that healthy collagen 
formation occurs. 
Mechanical loading of skeletal muscle and tendon, whether it be compression, stretch, 
or IASTM elicits largely the same response (Hammer, 2008). As previously described this 
response begins with the activation and eventual proliferation of fibroblast cells in the extra-
cellular matric (ECM). These specialized cells produce collagen, elastin, cytokines and growth 
factors that aid in the growth and repair process. In instances of extreme mechanical loading of 
muscle and tendon, as is often seen in injured tissue, the cytokine signaling is markedly pro-
inflammatory and this is also seen following therapeutic mechanical loading of muscle and 
tendon (Hammer, 2008).  
 Though it is unknown if IASTM initiates collagen realignment it is known that the 
realignment of collagen tissue is vital for physiologically and biomechanically sound tissue 
(Alfredson, Thorsen, & Lorentzon, 1999). Classically, it has been thought that collagen synthesis 
was initiated by inflammatory cell activation and proliferation but more recent, controlled, 
histological data have demonstrated this is false (Alfredson et al., 1999; Langberg et al., 2007; 
Movin, Gad, Reinholt, & Rolf, 1997) .  
For example, the sports medicine community has long considered prostaglandin E2 
elevation to be a powerful initiator of collagen synthesis and therefore encouraged patients to 
not take prostaglandin inhibiting pharmaceuticals after the acute inflammatory stage of injury. 
25 
 
However, in situ models have demonstrated that prostaglandin activation and proliferation 
does not correlate with re-alignment (Alfredson et al., 1999). Further, it has been demonstrated 
that intertendinous glutamate levels correlate with collagen alignment (Alfredson et al., 1999) 
at a much higher level. This glutamate correlation was groundbreaking as it demonstrates that 
the presence glycosaminoglycan’s must play a viable role in healthy collagen synthesis and re-
alignment (Langberg et al., 2007). The glutamate correlation is hard to argue against because 
subjects with tendinopathy expressed a 4 fold increase in glutamate when compared with 
healthy controls (Alfredson et al., 1999).  
 
2.4.6 Possibility of ECM Integrin Response 
In order for a stimuli such as stretch or strain to result in molecular signaling, physical 
alterations in the cell membrane and the extra cellular matrix ECM appear to be transmitted 
through intermediate activating proteins known as integrin’s (Carson & Wei, 2000). Integrins in 
turn activate several intracellular kinases that initiate mechanotransduction signals including 
focal adhesion kinase (FAK) and the mitogen-activated protein kinase (MAPK) family of 
proteins. Skeletal muscle is sensitive to several types of stretch (Hornberger, Armstrong, Koh, 
Burkholder, & Esser, 2005; Kumar, Chaudhry, Reid, & Boriek, 2002), and upon stretch 
activation, these kinase cascades activate regulatory molecules that largely control protein 
synthesis, glucose uptake, and immune cell recruitment and activation status (Cara, Kaur, 
Forster, McCafferty, & Kubes, 2001). Any physiological benefits due to soft tissue mobilization 
would likely be initiated through mechanical effects on skeletal muscle followed by changes to 
intracellular regulatory cascades (Crane et al., 2012).  
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In order to explore the mechanism by which soft tissue mobilization may alter molecular 
signaling in muscle Crane et al. used a human subject’s massage study design. Crane et al. 
obtained muscle biopsies from 11 young male subjects at rest, immediately after administration 
of massage to a randomized, single leg and after a 2.5-hour period of recovery. Crane et al. 
used whole-genome microarrays to screen for expressed genes induced by massage. After 
identifying functional categories from the array assay, they performed targeted real-time 
reverse transcription–polymerase chain reaction (RT-PCR), protein signaling analysis (Western 
Immunoblots), and metabolite quantifications to more completely characterize possible 
signaling pathways within skeletal muscle that are influenced by massage. Results indicated 
that massage activated the mechanotransduction signaling pathways FAK and extracellular 
signal–regulated kinase 1/2 (ERK1/2), initiated mitochondrial biogenesis signaling [nuclear 
peroxisome proliferator–activated receptor γ coactivator 1α (PGC-1α)], and shunted the rise in 
nuclear factor κB (NFκB) (p65) nuclear accumulation caused by exercise-induced muscle 
damage. Further, it was found that massage attenuated the production of the pro-
inflammatory cytokines tumor necrosis factor–α (TNF-α) and interleukin-6 (IL-6) and reduced 
heat shock protein 27 (HSP27) phosphorylation, thereby mitigating cellular stress resulting from 
muscle damage (Crane et al., 2012).  
 
2.4.7 Possible Role of the Alpha7Beta1 Integrin 
The alpha7beta1 integrin is a mechanoreceptor that relays membrane stretch signals to 
the cytoplasm through focal adhesion kinase (FAK), which can then relay the signal through cSrc 
and ERK1/2 (Graham, Vardiman, Siedlik, Deckert, & Gallagher, 2014). Though it is logical that 
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the chemical and structural changes in skeletal muscle following soft tissue mobilization are 
mediated by this integrin no lab has found changes in this integrin’s number or activation status 
following IASTM treatment. Additionally, the only research group to examine the effects of 
IASTM on integrin signaling found no significant changes in signaling in the gastrocnemius 
following treatment (Graham et al., 2014) .  
However, it is important to note that our research study exploring the relationship 
between integrin count and activation status occurred in non-injured populations where the 
studies that cited alterations in integrin’s used injury models. These data from our lab suggest 
that IASTM did not have any effect on the gene expression, protein expression, or 
phosphorylation status of the Alpha 7 Beta 1 Integrin (Graham et al., 2014). Further research 
should examine other integrin’s and should also explore whether injury status effects integrin 
response. 
 
2.5 Neural Response to Soft Tissue Mobilization 
2.5.1 Effect of massage on Neuromuscular Excitability and the Hoffman Reflex 
 It has long been thought that massage and other similar techniques stimulate sensory 
receptors and decrease muscle tension by decreasing neuromuscular excitability (M Morelli, 
Chapman, & Sullivan, 1998; Moreno Morelli, Seaborne, & Sullivan, 1991; Moreno Morelli, 
Seaborne, & Sullivan, 1990; Sullivan, Williams, Seaborne, & Morelli, 1991). The body of 
literature exploring this phenomena is small but consistent in this finding. When neuromuscular 
physiologists wish to explore neuromuscular excitability they generally use the Hoffman Reflex 
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(H-reflex) as the outcome variable. H-reflex is a valuable assessment tool as its amplitude is 
analogous with stretch reflex loop behavior (Weerapong & Kolt, 2005). It has been successfully 
demonstrated that IASTM intensity does correlate with H-Reflex response (Goldberg, Sullivan, 
& Seaborne, 1992). However, one must keep in mind that the intensity and duration of 
treatment are vastly different between massage and IASTM.  
 There appears to be a link between massage and neuromuscular adaptation but it is 
unclear if IASTM evokes similar responses. In order to identify if testing the effect of IASTM on 
sensory receptor stimulation and subsequent decreases in neuromuscular excitability is a 
worthwhile research track one must first understand the basic biomechanics of massage. 
Petrissage, the type of massage used in the massage/H-reflex research features characteristic 
mechanical compression as well as kneading motions. This kneading motion is not easily 
replicated through IASTM. Further, massage treatments generally last longer and utilize lower 
pressure forces. None the less, massage and IASTM are similar so it is not outside the realm of 
possibility that they effect neuromuscular excitability in similar ways. 
 One study by Morelli et al. used six minutes of one handed petrissage and performed a 
series of H-Reflex tests to explore the effect of massage on neuromuscular excitability (Moreno 
Morelli et al., 1990). Researchers observed that during the massage treatment there was a 
decrease in H-Reflex amplitude that is characteristic of decreased excitability (Moreno Morelli 
et al., 1990). However, it was observed that immediately following completion of the treatment 
H-Reflex characteristics returned to normal, baseline values. Morelli, in another paper, 
described that he believed the mechanism behind the decrease in H-Reflex amplitude was likely 
due to a decrease in spinal reflex excitability (Moreno Morelli et al., 1991). Further, Morelli 
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adds that this phenomena only occurs locally (Sullivan et al., 1991), in the muscles that received 
treatment.  
 Morelli hypothesized that the inhibitory effects of neuromuscular excitability by 
massage could be the reason for the common anecdotal findings reported in hundreds of case 
studies that massage decreases resting muscle tension. However, it does not appear the 
reduction of H-reflex amplitude is the cause for observed post massage decreases in muscular 
strength as reported by Wiktorsson-Moller et. el (Wiktorsson-Moller et al., 1983).  The most 
compelling finding that decreases in H-reflex are not the reason for strength losses post 
massage is that H-reflex returns to “resting” value immediately upon completion of the 
treatment whereas strength losses can be present for days (Weerapong & Kolt, 2005). Further 
research is needed to understand the mechanism by which these strength losses occur. 
Additionally, further research is needed to be able to determine if IASTM effects localized 
neuromuscular tissue in a similar way. 
 
2.5.2 Proposed Neural Mechanism 
 In an effort to explore the mechanism of the decreased H-Reflex amplitude found in the 
Morelli et al original studies the Morelli research group designed a follow up study (M Morelli 
et al., 1998). The purpose of this study was to explore if cutaneous receptors contribute to the 
changes in the amplitude of the H-reflex during massage. In order to test this hypothesis 
subjects were randomly assigned to one of two groups. One was a control group and the other 
a cutaneous receptor “knock down” group that utilized a local anesthetic to accomplish this end 
(M Sabbahi & De Luca, 1981; MA Sabbahi & De Luca, 1982; Wolf & Minkwitz, 1989). 
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There was a marked increase in H-Reflex amplitude in both groups compared to the pre-
massage tests but no group x time interaction. The fact that there was no group x time 
interaction suggests that the mechanism by which massage increases H-Reflex amplitude is 
likely independent of cutaneous sensory neuron stimulation.  
 
2.6 The Use of Diagnostic Ultrasound to Assess Changes in Muscle Architecture 
 Examining muscle size, pennation angle and tissue quality in-vivo is useful when trying 
to determine the effectiveness of IASTM and other therapeutic modalities. These variables can 
be reliably explored in the hamstrings muscles using modern diagnostic ultrasound imaging 
(Palmer, Akehi, Thiele, Smith, & Thompson, 2015). Diagnostic ultrasound has been successfully 
used to document changes in skeletal muscle architecture caused by training (Ahtiainen et al., 
2010), aging (Roth et al., 2001), immobilization (Abe, Kawakami, Suzuki, Gunji, & Fukunaga, 
1997) and neuromuscular disease (Moreau, Teefey, & Damiano, 2009). In addition to the 
measurement of muscle size, thickness and pennation angle more modern measurements 
including muscle quality (echo intensity) are being utilized to assess the ratio of muscle to fat 
and fibrous content (Pillen et al., 2009). Muscle quality appears to be a variable that can change 
with training status (Palmer et al., 2015). For example, it has been demonstrated that 6 weeks 
of isokinetic resistance training can lead to alterations in muscle quality (Cadore et al., 2014).  
Though cross sectional area, muscle thickness, pennation angle and muscle quality as measured 
by echo-intensity are all trainable it remains unclear if any of these architectural variables are 
altered by soft tissue mobilization. 
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2.7 Summary:  
 In summary, more research is needed to explore the ability of IASTM treatments to alter 
the chemical and physical property of skeletal muscle. One confounding factor is how many 
forms of soft tissue mobilization there are. While IASTM and massage appear quite similar, it is 
difficult to know if application can be drawn from one form of soft tissue mobilization to the 
next.  
 Further research is needed to better understand the link between the therapeutic 
mechanical loading of soft tissue and the mechanism by which positive benefits occur. Better 
understanding of this mechanism will aid clinicians in better prescription of therapeutic 
modalities and could lead to quicker return to work following musculoskeletal injury. Crain et al 
has suggested that this mechanism is integrin initiated and ultimately carried out by production 
of growth and repair factors in localized fibroblast. This hypothesis is logical but needs further 
study to be substantiated. In addition to the further exploration of this proposed mechanism 
researchers should explore interactions between therapeutic mechanical loading of muscle and 
other therapeutic modalities as well as common, over the counter analgesics. 
The effect of IASTM on neuromuscular physiology is largely understudied as well. The 
body of research that has demonstrated massages ability to alter H-reflex is perhaps the most 
compelling at suggesting IASTM potentially does affect the neuromuscular function of skeletal 
muscle. The fact that massage has repeatedly been shown to transiently increase H-Reflex 
amplitude during treatment suggests massage (and potentially other forms of soft tissue 
mobilization) plays a role in the alteration of basal neuro-muscular activity. However, Morelli et 
al proved its own cutaneous sensory fiber activation theory wrong in their subsequent follow 
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up study. Future research should explore the mechanism by which massage effects H-Reflex 




Chapter 3: Methods 
3.1 Study 1- Instrument-assisted soft tissue mobilization: effects of on the properties of 
human plantar flexors  
3.1.1 Subjects 
 11 healthy men (mean±SD age=23±3 years; stature=181±7 cm; mass=83±11 kg) 
volunteered for this investigation. Each participant was screened for current or ongoing 
neuromuscular diseases, musculoskeletal injuries, or skin disorders specific to the plantar 
flexors. Participants reported that they had neither recently taken nor were currently using 
non-steroidal anti-inflammatory drugs (NSAID), aspirin, or other anti-thrombotic over-the-
counter or prescription medications. Participants were instructed not to participate in exercise 
24 h prior to their first scheduled visit to the laboratory or throughout the 4 subsequent days 
during data collection. This study was approved by the University Institutional Review Board for 
Human Subjects, and all participants completed a written informed consent form and a Health 
& Exercise Status Questionnaire. This study also meets the ethical standards established by the 
International Journal of Sports Medicine (Harriss & Atkinson, 2011). 
 
 3.1.2 Study Design 
 A repeated measures design was used to examine the acute effects of the IASTM on 
plantar flexors musculotendinous stiffness (MTS), passive range of motion (PROM), maximal 
voluntary contraction peak torque (MVPT), perception of functional ability questionnaire 
(PFAQ) responses, intramuscular levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-
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α) cytokines. Participants visited the laboratory 5 times. The first day included familiarization 
with the protocol, screening for inclusion and exclusion criteria and signing the IRB approved 
informed consent document. The second visit was within 7 days of the initial visit and was the 
first of four concurrent days of data collection. The first day of data collection included random 
assignment of the IASTM treatment leg (TL), muscle biopsy 1 (MB1) from the control leg (CL), 
pre-IASTM isokinetic assessment of the TL and CL, the IASTM treatment protocol to the TL and 
the post-IASTM isokinetic assessment of the TL and CL. The post-IASTM assessments occurred 
immediately after the treatment. The subsequent three visits included muscle biopsy of the TL 
only and isokinetic assessment of the TL and CL. All experimental trials were performed at the 
same time of day (±15 min). 
 
3.1.3 Muscle Tendon Stiffness 
 Musculotendinous stiffness of the plantar flexors was quantified. MTS is the ability of 
the combined musculotendinous unit to prevent a change in length when force is applied 
(Pearson & McMahon, 2012). MTS was calculated for each 1° increment in the passive angle-
torque relationships from the neutral ankle position of 0° (i. e., 90° between the foot and leg) to 
the end of the range of motion. The ROM for each measure was determined using the position 
signal from the isokinetic dynamometer. The final MTS value that was calculated for the joint 
angles commonly achieved during both the pre- and post-treatment trials was analyzed. For 
example, if MTS values were obtained for a subject at 10°, 11° and 12° during the pre-
treatment assessment, and MTS values were calculated at 10°, 11°, 12° and 13° for the post-
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treatment assessment, then the values at 12° were used for analysis, because this joint angle 
was common to both the pre- and post-treatment assessments. 
MTS was measured using a fourth-order polynomial regression model that was fitted to the 
passive angle-torque curves for each subject (Nordez, Cornu, & McNair, 2006). The fourth-order 
polynomial model was chosen over other models (i. e., second-order polynomial and Sten-
Knudson) based on the comparative recommendation of Nordez (Nordez et al., 2006) and 
because the fourth-order polynomial is classically used in the literature to assess in vivo MTS 
(Magnusson, Simonsen, Aagaard, Sørensen, & Kjaer, 1996; Magnusson, Simonsen, Aagaard, & 
Kjaer, 1996; Riemann, DeMont, Ryu, & Lephart, 2001). MTS quantifies the joint angle-specific 
stiffness of the musculotendinous unit based on the passive angle-torque relationship. No 
gravity correction was performed, as based on the methods of Salsich et al, (Salsich, Mueller, & 
Sahrmann, 2000) who indicated that the foot constituted approximately 1.4% of the body’s 
mass and suggested that this mass can be considered negligible (T. Herda et al., 2009). Values 
utilized in analysis were slope values from three common joint angles across all subjects (T. 
Herda et al., 2009). 
3.1.4 Passive Range of Motion 
 The passive range of motion (PROM) of the plantar flexors was determined for each 
participant during the pre- and post-treatment assessments using the isokinetic dynamometer 
programmed in passive mode. PROM is the measure of the terminal end of motion in a joint 
facilitated by passively moving the limb. This is typically determined by the patient’s subjective 
indication of when the limbs movement becomes painful (T. J. Herda, Cramer, Ryan, McHugh, & 
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Stout, 2008). Maximum PROM was determined for each individual during the trial as the point 
of discomfort, but not pain, as verbally acknowledged by the subject during a passive stretch of 
the plantar flexors while the leg was in terminal knee extension. The dynamometer lever arm 
passively dorsiflexed the foot at an angular velocity of 5°/s until the end range of motion. PROM 
was calculated as the range of motion attained from 0° (neutral) to the maximum tolerable 
point of passive dorsiflexion. No gravity correction was performed based on the methods of 
Muir (Muir, Chesworth, & Vandervoort, 1999), who indicated that the foot constituted 
approximately 1.4% of the body’s mass (Winter, 2009) and suggested that this mass can be 
considered negligible. 
 
 3.1.5 Maximal Voluntary Contraction Peak Torque 
 To determine maximal voluntary contraction peak torque (MVPT), each participant 
performed two 5-s isometric MVCs of the plantar flexors at a neutral ankle joint angle (0°=90° 
between the foot and leg), while the knee joint was in terminal knee extension. The MVPT is 
the force produced at a specific angle in a patient’s range of motion. A 2-min rest was allowed 
between trials. The MVPT for each trial was determined as the highest consecutive 0.25 s 
epoch. The same 0.25 s epoch were selected for the EMG signals to calculate the time domain 
estimates during the MVC trials. The mean PT value from the 2 MVC trials was used as the 
representative score for further analyses. The participants were instructed to give a maximum 




3.1.6 Surface EMG Collection 
 EMG was collected to ensure all PROM assessments were passive according to Gajdosik 
et al. (2005). Bipolar, active surface EMG electrodes were placed on the medial gastrocnemius 
(MG) and soleus (SOL) muscles. The electrode configuration (TSD150B, Biopac Systems Inc.; 
Santa Barbara, California, USA) had a fixed center-to-center interelectrode distance of 20 mm, 
built-in differential amplifier with a gain of 350 (nominal), input impedance of 100 MΩ, and 
common mode rejection ratio of 95 dB (nominal). For the SOL, the electrodes were placed 
along the longitudinal axis of the tibia at 66% of the distance between the medial condyle of 
the femur and the medial malleolus. The electrodes for the MG were placed on the most 
prominent bulge of the muscle per the recommendations of (Hermens, Freriks, Disselhorst-
Klug, & Rau, 2000). A single pre-gelled, disposable electrode (Ag-Ag Cl, Quinton Quick Prep, 
Quinton Instruments Co., Bothell, Washington, USA) was placed on the spinous process of the 
seventh cervical vertebrae to serve as a reference electrode. To reduce interelectrode 
impedance and increase the signal-to-noise ratio, local areas of the skin were shaved, lightly 




3.1.7 Signal Processing 
 The EMG and torque signals were recorded simultaneously with a Biopac data 
acquisition system (MP150WSW, Biopac Systems, Inc. Santa Barbara, California, USA) during 
each MVPT and PROM assessment. The for torque (Nm) data, signals from the dynamometer 
and EMG (μV) signals were sampled at 2 kHz and recorded from the SOL and MG. All signals 
were stored on a personal computer (Dell Inspiron 8200, Dell, Inc., Round Rock, Texas, USA), 
and processing was completed off-line using custom written software (LabVIEW v 7.1, National 
Instruments, Austin, Texas, USA). The EMG signals were digitally filtered (zero-lag fourth-order 
Butterworth filter) with a pass band of 10–500. The torque signal was low-pass filtered with a 
10 Hz cutoff (zero-phase fourth-order Butterworth filter). All subsequent analyses were 
performed on the filtered signals. 
 
3.1.8 PFAQ Questionnaire 
 The Perception of Functional Ability Questionnaire (PFAQ) was developed by panel of 
physicians, athletic trainers, and patients. Six critical domains were identified for the 
assessment of functional ability during a functional task: physical health, flexibility, muscular 
strength, pain, restriction of sport, skill, and activity of daily living (ADL) performance. To assess 
the six domains, an 8-question questionnaire with associated visual analogue scale from 0–10 
was developed. The PFAQ was evaluated for test-retest reliability using 60 college-aged 
students following procedures described by Levine (Levine et al., 1993). Internal consistency 
was assessed for all items collectively using Chronbach’s alpha (=0.856), with a score of 0.8 
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being considered good and 0.9 excellent. Each participant completed the PFAQ prior to the 
muscle biopsy and isokinetic testing on each of the testing days. 
3.1.9 IASTM Treatment Dosage 
 The IASTM protocol was administered by a certified athletic trainer with over 13 years 
of experience. On day 1, subjects underwent the IASTM protocol on the plantar flexors of the 
randomly assigned TL. The IASTM was a 7–8 min, soft-tissue mobilization protocol using one 
convex shaped and one concave shaped stainless steel instrument designed for IASTM. The 
plantar flexors of the TL were divided into 4 treatment sections. Each section received 3 sets of 
7 strokes in both proximal and distal directions. A bubble level was applied to both instruments 
to provide the clinician with a consistent treatment angle of 45°. Flexiforce-Economical Load 
and Force pressure sensors (ELF™) (Tekscan, South Boston, MA) were applied to the 
instrument’s treatment surface to ensure standardized treatment pressures throughout the 
protocol. Measures of peak and mean pressure for each of the 4 treatment quadrants were 
quantified using LabVIEW (LabVIEW v 7.1, National Instruments, Austin, Texas, USA). 
 
3.1.10 Muscle Biopsies 
 On each day following the collection of ROM, and Passive Torque data, percutaneous 
muscle biopsies (~100 mg) (Bergstrom, 1962) were taken from the gastrocnemius. The baseline 
biopsy was taken from the control leg while the other biopsies (-immediately post, -24 post, 48 
post and 72 post) were taken from the treatment leg. This methodology was used to avoid 
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biopsy induced inflammation from confounding the immediately post treatment biopsy values. 
All biopsies were obtained from the mid-belly region of the muscle, and each biopsy was 2–
3 cm proximal from the previous site and within the region treated by IASTM. Each subject 
received standard antiseptic application to each biopsy site followed by an injection of 3 cc of 
local anesthetic (2% lidocaine) to each biopsy site. The subject then rested for 5 min to ensure 
that the area was sufficiently anesthetized. An incision approximately 0.5 cm wide and 1 cm 
deep was then made using a scalpel (#11 Blade) approximately 6–8 cm from the joint line of the 
knee. All samples were then placed in liquid nitrogen and stored at −80°C until analysis. 
 
3.1.11 Muscle Processing 
 Approximately 20 mg of each muscle sample was homogenized in extraction buffer 
(Biosource; Carlsbad, CA) using a glass-on-glass tissue grinder. Homogenized samples were 
centrifuged at 4°C at 3 000 rpm for 4 min. For determining total protein, supernatant was 
separated from the pellet and the sample was diluted (1:1 000) in preparation for analysis using 
a bicinchoninic acid (BCA) protein assay (Pierce; Rockford, IL). All samples were measured in 
triplicate using a Synergy microplate reader (BioTek, Winooski, VT) at 450 nm. 
 
3.1.12 Western Immuno-Blotting 
 Muscle samples were diluted with 5x buffer (IL-6) or 1x buffer (TNF-α) and heated for 
3 min at 100°C. 80 µg of protein was loaded for each sample and placed on a 5% stacking and 
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10% separating gel at 0.05 mA for 1 h. Proteins were transferred to hydrophobic polyvinylidene 
difluoride (PVDF) membranes at 0.20 mA for 2 h. Membranes were blocked for 1 h in a Tris-
buffered saline with 5% nonfat dry milk on a rocker at room temperature. Membranes were 
then incubated at 4°C on a plate rocker overnight in a 1:1 000 IL-6 (Cell Signaling Technology, 
Inc., Beverly, MA) or TNF-α antibody (Cell Signaling Technology, Inc., Beverly, MA) which was 
normalized to tubulin (Cell Signaling Technology, Inc., Beverly, MA) in TBST and 1% nonfat dry 
milk solution. Following the overnight incubation, membranes were rinsed 3 times for 5 min in 
TBST. Membranes were incubated in horseradish peroxidase conjugated secondary antibody 
for an hour and once again rinsed 3 times for 5 min in TBST. Membranes were then incubated 
in chemiluminescence. IL-6 and TNF-α (Santa Cruz Biotechnology, Santa Cruz, CA) protein bands 
were then visualized and quantified using densitometry (AlphaView® FluorChemHD2 v.3.4.0.0, 
Protein Simple, Santa Clara, CA). 
  
3.1.13 Statistical Analyses 
 3 separate 2×5 repeated measures ANOVAs [Leg (CL vs. TL)×Time (pre-IASTM, post-
IASTM, day 2, 3, and 4)] were used to analyze MTS, PROM, and MVPT data. Three separate one-
way repeated measures ANOVAs were used to analyze PFAQ, IL-6 and TNF-α. When 
appropriate, follow-up analyses were performed using paired samples t-tests and with 
Bonferroni’s corrections. Mauchly’s sphericity test was also run for each of the previously 




3.2 Study 2- The effects of different IASTM pressure volumes on the passive properties 
of skeletal muscle  
3.2.1 Subjects 
 Forty-three healthy college aged subjects (mean±SD age=23±3 years; height=181±7 cm; 
mass=83±11 kg) volunteered for this investigation. Each participant was screened for current or 
ongoing neuromuscular diseases, musculoskeletal injuries, or skin disorders specific to the 
plantar flexors. Participants reported that they had neither recently taken nor were currently 
using non-steroidal anti-inflammatory drugs (NSAID), aspirin, or other anti-thrombotic over-
the-counter or prescription medications. Participants were instructed not to participate in 
exercise 24 h prior to their first scheduled visit to the laboratory or throughout the 4 
subsequent days during data collection. This study was approved by the University Institutional 
Review Board for Human Subjects, and all participants completed a written informed consent 
form and a Health & Exercise Status Questionnaire. This study also meets the ethical standards 
established by the International Journal of Sports Medicine (Harriss & Atkinson, 2011). 
 
3.2.2 Study Design 
 A four group (control, sham, reduced IASTM pressure, clinical IASTM pressure) repeated 
measures design was used to examine the effects of  IASTM pressure force dosages on calf 
muscle musculotendinous stiffness (MTS), passive range of motion (PROM), maximal voluntary 
contraction peak torque (MVPT) and perception of functional ability questionnaire (PFAQ) 
responses. Once participants were recruited and an IRB approved informed consent document 
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was obtained participants were asked to come in for a total of three testing visits. On the first 
visit an emollient sensitivity trial was performed. The purpose of this was to examine if 
participants were allergic to the topical emollient that would be used during the IASTM 
treatment.  Upon completion of this test and a health history questionnaire, participants were 
asked to fill out the PFAQ questionnaire and went through MVC and PROM testing. These 
values served as baseline values. Upon collection of these baseline values participants were 
given treatment based on the group they were assigned to. When the assigned treatment was 
completed subjects were once again tested using the same battery of tests. This “immediately 
post” test marked the end of visit one.  Visit two and three were scheduled -24 and -48 hours 
post treatment, respectively. These visits consisted of having participants fill out the PFAQ 
questionnaire and go through the previously described MVC and PROM testing. 
 
3.2.3 Muscle Tendon Stiffness 
 MTS data collections were carried out using the methodology previously described in 
section 3.1.3. 
3.2.4 Passive Range of Motion 
 







3.2.5 Maximal Voluntary Contraction Peak Torque 
MVC-PT data collections were carried out using the methodology described in 3.1.5. 
 
3.2.6 Surface EMG Collection 
sEMG data collections were carried out using the methodology described in 3.1.6. 
 
3.2.7 Signal Processing 
 sEMG raw signals were collected and post processed using LabVIEW (LabVIEW v 7.1, 
National Instruments, Austin, Texas, USA). This was carried out using the methodology 
described in 3.1.7. 
 
3.2.8 PFAQ Questionnaire 
 The PFAQ was administered at the beginning of each visit and twice on visit one in 
accordance the methodology outlined in section 3.1.8. 
 
3.2.9 IASTM Treatment Dosage 
 The IASTM treatments were the same as previously described in section 3.1.9 with one 
exception. Due to the nature of the research question there were two different groups 
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receiving IASTM treatment. The “clinical pressure” group received its treatment in exact 
accordance with the previously described method. The sub-clinical group received the same 
total volume of treatment at a lower pressure intensity. The mean and peak pressure for the 
scanner tool were 1.1± .54 N/𝑚𝑚𝑚𝑚2 and 2.1± .93 N/𝑚𝑚𝑚𝑚2 respectively. The mean and peak 
pressure for the concave tool were 1.0± .32 N/𝑚𝑚𝑚𝑚2 and 2.2± .84 N/𝑚𝑚𝑚𝑚2 respectively. These 
values were determined by taking the mean of individuals mean values and the mean of the 
peak pressure values respectively.  
   
3.2.10 Pressure force quantification 
 Pressure forces were quantified using a modified load-cell apparatus that was machined 
in house (Figure 1). Voltage signals were collected using a custom written signal acquisition 
program (LabVIEW v 7.1, National Instruments, Austin, Texas, USA). Post processing and 








Figure 1: Custom load-cell device attached to each tool 
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3.2.11 Statistical Analyses 
 Three separate 2x3×2 repeated measures ANOVAs [leg(treatment vs 
control)xgroupxtime] were used to analyze MTS, PROM and MVPT data.  The immediately, -
24hr and -48hr post time points were collapsed into one “post” time point. This was done to 
more clearly describe the data and to simplify the statistical model for ease of interpretation for 
clinicians.  A 3x2 (groupxtime) mixed factorial ANOVA was used to examine changes in PFAQ 
response. When appropriate, follow-up analyses were performed using paired samples t-tests 
with Bonferroni’s correction for type-1 error. Mauchly’s sphericity test was also run for each of 




3.3 The Effects of IASTM Treatment on Short Hamstring Syndrome in College Aged 
Adults 
3.3.1 Study Design 
 To examine the abilities of IASTM to alter skeletal muscle architecture a repeated measures 
study design was utilized. Participants were asked to come in for two visits with a one week wash-out 
between visits. Subjects received -pre testing, -post testing as well as a treatment (IASTM or Sham) on 
each visit.  
3.3.2 Subject Recruitment 
The purpose of this investigation was to examine the effects of IASTM on the flexibility 
and hamstrings muscle architecture (biceps femoris) in clinically-identified hamstring-restricted 
college-aged adults. In order to accomplish this, we recruited 17 college-aged females (age= 
were recruited with clinically-identified restricted leg flexors were recruited (age= 21.12 ± 0.78 
years; height= 165.41 ± 7.66 cm; weight= 61.34 ±18.55 kg). However, there were certain 
exclusion criteria present. Namely, any subjects who had experienced traumatic injury to the 
lower extremity within the previous 3 months prior to participation. Additionally, anyone who 
has difficulty laying on their back for an extended period of time (> 1 hour) were excluded. 
Participant were asked to visit the lab on two occasions, for a total of three hours over the 
course of two weeks with a minimum of one week between testing (testing day 1 and 2). Once 
subjects were recruited they were classified into one of two groups.  
Subjects were situated on a cushioned table to assess hamstring flexibility. To determine 
whether a subject was considered range of motion restricted or not a straight leg passive 
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stretch assessment was utilized. During this straight leg raise assessment the subjects knee and 
ankle were immobilized (90° flexion at the ankle and 0° flexion at the knee). After subjects were 
fitted with proper immobilizers the investigator slowly elevated subject’s foot toward their 
head until they reached the point of mild discomfort prior to pain 
 
3.3.3 PFAQ and Survey of Treatment Quality Questionnaires 
 The PFAQ was administered prior to the beginning of all other testing on each visit. The 
PFAQ is more fully described in section 3.1.8. The survey of treatment quality was developed 
for this examination and is a four-item survey designed to qualitatively measure then 
perception of mood following IASTM. The survey of treatment quality was administered 
immediately following both the sham and the IASTM treatments. 
3.3.4 Range of Motion Assessment for Subject classification 
Subjects were situated on a cushioned table to assess hamstring flexibility. To determine 
whether a subject was considered range of motion restricted or not a straight leg passive 
stretch assessment was utilized. During this straight leg raise assessment the subjects knee and 
ankle were immobilized (90° flexion at the ankle and 0° flexion at the knee). After subjects were 
fitted with proper immobilizers the investigator slowly elevated subject’s foot toward their 
head until they reached the point of mild discomfort prior to pain. Additionally, a second range 
of motion assessment was completed during each visit both –pre and –post treatment or sham. 
During this assessment, the subject’s hips and knees were placed at 90 degrees respectively. 
Again, the investigator elevated the subjects foot upward toward their head until subjects 
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indicated they had reached the maximal amount of stretch without discomfort. During this 
range of motion assessments both the maximal ROM and ROM at which subjects began to feel 
a stretch were recorded. 
 
3.3.5 IASTM and Sham Treatment Dosage 
 The IASTM treatments were the same as previously described in section 3.1.9 aside 
from the treatment being applied to the hamstrings muscles rather than the gastrocnemius 
complex. The sham treatment was carried out using a therapeutic ultrasound machine 
(Chattanooga Medical Supply, Chattanooga, TN USA). The sham treatment lasted five minutes 
to match the IASTM treatment time. The ultrasound machine was not turned on during the 
sham treatment. 
3.3.6 Diagnostic Ultrasound Parameters  
 For diagnostic ultrasound assessments the subjects were placed in a prone position and 
the knee was extended and relaxed (Potier, Alexander, & Seynnes, 2009). Subjects were 
instructed to lie prone for five minutes prior to image collection to allow for intramuscular fluid 
shifts to occur. Ultrasound data were collected using the NextGen LOGIQ e ultrasound console 
(GE Healthcare UK, Ltd., Chalfont, Buckinghamshire, UK) with a multi-frequency linear array 
transducer (Model 12L-RS; 5-13 MHz; 38.4 mm field-of-view). The ultrasound probe was placed 
at the midpoint of the femur from the greater trochanter to the lateral epicondyle of the femur 
for the BF muscle (Umegaki et al., 2015) and its position was marked on the skin to ensure 
uniformity between pre and post ultrasound measurements (Potier et al., 2009) (Figure 2). 
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Once the probe was properly placed two images were taken and stored digitally for analysis of 
pennation angle (Potier et al., 2009).  
 
Figure 2: Panoramic Scan of Hamstrings Muscle 
 
Upon collection of B-mode ultrasound images we began collecting panoramic 
ultrasound signal in order to determine biceps femoris cross-sectional area and muscle quality 
(echo intensity). The muscle belly of the biceps femoris was carefully outlined in ImageJ 
(ImageJ, National Institute of Health, Bethesda, Maryland, USA). The mean echo intensity of this 
region was next calculated with a standard histogram function (Pillen et al., 2009). The Image J 
histogram function isolates each pixel and assigns an echo intensity value between 0 (black) 
and 255 (white) as is consistent with 8-bit greyscale post-processing (Pillen et al., 2009). The 
same outline was used for determination of biceps femoris cross-sectional area. During the 





Figure 3: Outline of Biceps Femoris used for CSA and Echo Intensity determination 
 
 
Pennation angle was defined as the positive angle between the superficial aponeurosis 
and the muscle fascicle (Gajdosik, Rieck, Sullivan, & Wightman, 1993; Potier et al., 2009; 
Woodley & Mercer, 2005).   
3.3.7 Dynamic Ultrasound Measurements 
In addition to the previously described prone images a series of dynamic ultrasound 
measurements were taken. All dynamic measurements were taken in B-mode to quantifying 
pennation angle. Measurements were taken with the subject’s hip and knee at ninety degrees 
as well as the ROM where participants first perceived stretch of the hamstrings and the 





















To analyze the panoramic ultrasound (CSA and Echo Intensity) two separate 2x2x2 
(groupxTreatmentxTime) ANOVA were utilized. Similarly, to analyze pennation angle at the 
three previously described joint angles three separate 2x2x2 (GroupxTreatmentxTime) ANOVA 
were utilized. Lastly, to statistically analyze the range of motions at the first perception of 
stretch as well as the maximal allowable stretch two additional 2x2x2 (GroupxTreatmentxTime) 
ANOVA were utilized. PFAQ data were analyzed using one way ANOVA. The Survey of 
Treatment Quality was analyzed using paired samples T-tests. Independent statistical analysis 




Figure 4:Visual depiction of the ROM where three dynamic B-mode 
measurements were taken 
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Chapter 4: Results 
4.1 Study 1- Instrument-assisted soft tissue mobilization: effects of on the properties 
of human plantar flexors  
4.1.1 MTS 
 For MTS, there were no significant two-way interactions (time×treatment, p=0.92) and 
no significant main effects for time (p=0.63) or treatment (p=0.89) (Figure 2).  
Figure 5: MTS was unaltered by treatment and time 
 
4.1.2 Passive range of motion 
 For PROM, there were no significant two-way interactions (time×treatment, P=0.78) and 











 For MVPT, there were no significant two-way interactions (time×treatment, P=0.25) and 


















Figure 7: Maximal voluntary contraction peak torque was 
unaltered by treatment and time 
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4.1.4 Myokine Expression 
 For IL-6, there were no significant differences (p=0.82) at any point in time following 
IASTM. For TNF- α, there were no significant differences (p=0.68) at any point in time following 
IASTM treatment (Figure 5). 
 
Figure 8: Protein expression values were quantified indirectly by imaging luminescence after 





Figure 9: Individual TNF-α expression values following IASTM treatment 
 
 
























































4.2 Study 2- The effects of different IASTM pressure volumes on the passive properties 
of skeletal muscle  
4.2.1 Muscle-Tendon Stiffness 
As previously described, a 2x3×2 mixed factorial, repeated measures ANOVA 
[leg(treatment vs control)xgroupxtime] was used to analyze MTS results. ANOVA revealed no 
significant interactions or main effects (Table 2). 
 
Table 2: MTS ROM-ANOVA results 
Term P value Partial Eta Squared 
GroupxTimexLeg interaction p= 0.621 = 0.032 
TimexLeg interaction p= 0.637 = 0.008 
LegxGroup interaction p= 0.985 =0.001 
TimexGroup interaction p= 0.254 =0.090 
Time main effect p= 0.605 =0.009 
Leg main effect p= 0.320 =0.034 


















Figure 11: Graphs displaying mean MTS values across time (-pre and -post). Statistical analysis 
revealed no interactions or main effects for MTS data. 
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4.2.2 Passive Torque 
As previously described, a 2x3×2 mixed factorial, repeated measures ANOVA 
[leg(treatment vs control)xgroupxtime] was used to analyze passive torque results. ANOVA 
revealed no significant interactions or main effects (Table 3).  
 
Table 3: Passive Torque ANOVA results 
Term P value Partial Eta Squared 
GroupxTimexLeg interaction p= 0.217 = 0.029 
TimexLeg interaction p= 0.394 = 0.025 
LegxGroup interaction p= 0.511 =0.045 
TimexGroup interaction p= 0.240 =0.094 
Time main effect p= 0.120 =0.081 
Leg main effect p= 0.355 =0.030 



































































Figure 12: Individual responses in passive torque at maximal 
range of motion 
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Figure 13: Graphs displaying mean Passive Torque values across time (-pre and -post). 







4.2.3 Range of Motion 
As previously described, a 2x3×2 mixed factorial, repeated measures ANOVA 
[leg(treatment vs control)xgroupxtime] was used to analyze ROM results. ANOVA revealed no 
significant interactions or main effects (Table 4). 
 
Table 4: Passive Torque ANOVA results 
Term P value Partial Eta Squared 
GroupxTimexLeg interaction p= 0.504 = 0.046 
TimexLeg interaction p= 0.952 = 0.000 
LegxGroup interaction p= 0.450 =0.054 
TimexGroup interaction p= 0.102 =0.146 
Time main effect p= 0.277 =0.041 
Leg main effect p= 0.693 =0.005 



















Figure 14: Graphs displaying mean maximal ROM values across time (-pre and -post). Statistical 






Table 5: Perception of Functional Ability Questionnaire collapsed across group 
Question p Value Partial Eta Squared 
Overall Health 0.154 0.038 
Overall Flexibility 0.120 0.042 
Overall Strength 0.205 0.033 
Calf Flexibility 0.201 0.036 
Calf Strength 0.233 0.031 
Calf Pain 0.099 0.055 
Calf Functional Ability 0.126 0.044 
Calf Ability to Carry out 






4.3 The Effects of IASTM Treatment on Short Hamstring Syndrome in College Aged 
Adults 
4.3.1 Hamstrings flexibility 
  There were no significant interactions or main effects concerning the range of motion 
at which participants reported sensation of initial stretch. Nor was there a between subject’s 
main effect for group (p=0.234).  
 
Figure 15: Hamstrings range of motion associated with initial stretch perception collapsed 
across treatment 
 
Table 6: ANOVA in hamstrings range of motion associated with initial stretch perception 
Term P value Partial Eta Squared 
TreatmentxTimexGroup p=0.389 =0.05 
TreatmentxTime p= 0.389 =0.105 
TimexGroup p= 0.207 =0.641 
TreatmentxGroup p= 0.184 =0.114 
Treatment p= 0.989  =0.000 
Time p= 0.556 =0.024 
 There was however a significant between subject’s main effect for group (p= 0.002).  
Pre Post Pre Post
Mean 129.38 127.00 154.00 155.11




Figure 16: Spaghetti plot displaying individual stretch perception responses to sham treatment 
 
Figure 17: Spaghetti plot displaying individual stretch perception responses to IASTM treatment 
 
 
Similarly, there were no significant interactions or main effects for maximal hamstrings 
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Figure 18: Hamstrings range of motion associated with maximal stretch perception collapsed 
across treatment 
 
Table 7: ANOVA in hamstrings range of motion associated with maximal passive stretch 
Term P value Partial Eta Squared 
TreatmentxTimexGroup p=0.127 =0.148 
TreatmentxTime p= 0.556 =0.024 
TimexGroup p= 0.294 =0.073 
TreatmentxGroup p= 0.391 =0.050 
Treatment p= 0.446 =0.039 
Time p= 0.446 =0.039 
 There was however a significant between subject’s main effect for group (p=-.00002).  
Pre Post Pre Post
Mean 150.50 148.38 168.00 169.89




Figure 19: Spaghetti plot displaying individual responses in maximal ROM to IASTM treatments 




Figure 20: Spaghetti plot displaying individual responses in maximal ROM to Sham treatments 
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4.3.2 Biceps fermoris muscle quality (echo intensity) 
 There were no significant interactions or main effects in the muscle quality of the biceps 
femoris as measured by ultrasound echo intensity. 
Figure 11: Biceps Femoris echo intensity (muscle quality) values collapsed across group 
Figure 21: Biceps Femoris echo intensity (muscle quality) values collapsed across group 
 
 
Table 8: ANOVA in muscle quality of the Biceps Fermoris 
Term P value Partial Eta Squared 
TreatmentxTimexGroup p=0.443 =0.040 
TreatmentxTime p= 0.395 =0.049 
TimexGroup p= 0.385 =0.051 
TreatmentxGroup p= 0.755 =0.007 
Treatment p= 0.616 =0.017 
Time p= 0.491 =0.032 
Similarly, there was no between-subjects main effect for group (p=0.160). 
 
 
Pre Post Pre Post
Mean 59.33624 55.72171 58.53512 58.94624





























































4.3.3 Biceps fermoris cross-sectional area 
 There were no significant interactions or main effects for cross-sectional area as 
measured using ultrasound. 
 
Figure 24: Biceps Femoris cross-sectional area values collapsed across group 
 
 
Table 9: ANOVA in Biceps Femoris Cross-sectional area 
Term P value Partial Eta Squared 
TreatmentxTimexGroup p=0.227 =0.096 
TreatmentxTime p= 0.564 =0.023 
TimexGroup p= 0.582 =0.281 
TreatmentxGroup p= 0.795 =0.005 
Treatment p= 0.080 =0.191 
Time p= 0.132 =0.145 
Further, there was no between-subject main effect for the group (p=.996). 
  
Pre Post Pre Post
Mean 7.685118 7.473941 7.358588 7.252471





Figure 25: Individual changes in cross sectional area following IASTM treatment 
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4.3.4 Biceps fermoris pennation angle  
 There were no significant interactions or main effects in the pennation angle data 
barring a main effect for joint angle (p=.0001). It is important to note that the TreatmentxGroup 
interaction approached significance (p=.057). This indicates IASTM may be more beneficial for 
subjects who are suffering from range of motion restriction. 
 
 
Figure 27: Delta scores of pennation angle from the ninety degree position 
 IASTM Treatment Sham Treatment 
 
  Medium Stretch Max Stretch Medium Stretch Max Stretch 
  Pre Post Pre Post Pre Post Pre Post 
Mean -0.43 -1.74 -2.22 -2.70 -0.99 -1.59 -2.78 -2.24 






Figure 28: Spaghetti plot displaying individual responses in pennation angle in the un-stretched 
position following IASTM 
 
Figure 29: Spaghetti plot displaying individual responses in pennation angle in the un-stretched 
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Table 10: ANOVA in Biceps Fermoris pennation angle 
Term P value Partial Eta Squared 
TreatmentxAnglexGroup p= 0.945 =.004 
TreatmentxTimexGroup p= 0.528 =.027 
TreatmentxAngle p= 0.905 =.007 
TreatmentxTime p= 0.450 =.038 
AnglexGroup p= 0.988 =.001 
TimexGroup p= 0.344 =.060 
TreatmentxGroup p= 0.057 =.220 
Angle* p= 0.0001* =.684* 
Time p= 0.944 =.0001 




Figure 30: Spaghetti plot displaying individual responses in pennation angle at the 90 degree 




Figure 31: Spaghetti plot displaying individual responses in pennation angle at the 90 degree 
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Figure 32: Spaghetti plot displaying individual responses in pennation angle at the mid-stretch 




Figure 33: Spaghetti plot displaying individual responses in pennation angle at the mid-stretch 
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Figure 34: Spaghetti plot displaying individual responses in pennation angle at the maximal 




Figure 35: Spaghetti plot displaying individual responses in pennation angle at the mid-stretch 
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4.3.5 Qualitative Assessments of Treatment Efficacy  
 There were no statistically significant interactions or main effects associated with the 
perception of functional ability data. 
 
 







Further, paired samples T-tests revealed IASTM didn’t evoke a sense of healing when compared 
with the sham treatment. 
 
Figure 36: Survey of Treatment Quality Results 
 
  
Treatment Sham p value Treatment Sham p value
Mean 3.53 3.18 3.59 3.18
SD 0.51 0.81 0.51 0.88
Question 1 Question 2
0.172 0.055
Question p Value Partial Eta Squared 
Overall Health 0.470 0.028 
Overall Flexibility 0.768 0.020 
Overall Strength 0.087 0.108 
Calf Flexibility 0.057 0.129 
Calf Strength 0.128 0.094 
Calf Pain 0.501 0.040 
Calf Functional Ability 0.109 0.100 
Calf Ability to Carry out Activities of Daily Life 0.106 0.129 
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Chapter 5: Discussion 
5.1 Discussion Intro 
Results from this multi-study examination of the effects of IASTM have suggested that 
IASTM may not be the most efficacious treatment available for degenerate soft-tissue. Our 
three investigations found no changes in MTS, PROM, MVC-PT, myokine expression, perception 
of functional ability as measured by the PFAQ, muscle quality (echo intensity), pennation angle 
or hip ROM.  However, there are considerations that should be made prior to passing 
judgement on IASTM as a treatment for soft tissue injury. These considerations include the role 
of IASTM as a small part of a larger treatment plan, the type of patient that IASTM is indicated 
for and the dosage parameters and frequency of treatments. 
5.2 IASTM as part of a larger treatment plan 
A recent review article examined the way IASTM should be used as a part of a larger 
treatment plan (Kim, Sung, & Lee, 2017). Using prior published peer-reviewed articles, they 




Table 12: IASTM as part of a larger treatment plan 
Treatment Objective Protocol Reference 
Warm-up ↑ Blood Flow 
↑ Muscle Temp 
↑ Plasticity 
10-15 light exercise 




IASTM ↓ Scar Tissue 
↑ Collagen Synthesis 
↑ Collagen Alignment 
40-120 seconds (Laudner, Compton, 
McLoda, & Walters, 
2014) 
Stretching Correct the shortened 
tissues and prevent re-
injury 
3 repetitions lasting 
30 seconds each  






Strengthen the treated 
tissue and prevent re-injury 
High repetition with 
low load 
(Hammer, 2008) 
Cryotherapy Reduce pain, control 
residual inflammation, and 
prevent secondary cell 
hypoxia 





This paper points out a paradox within the soft-tissue mobilization research body (Kim 
et al., 2017). In order to have more control over confounding variables researchers generally 
study one treatment at a time. While this is logical from a study design perspective it is 
detached from the reality that clinicians do not use IASTM as a stand-alone treatment. It is 
possible that other treatments (light exercise, stretching, and heat/cryotherapy) serve as a 
moderator of the IASTM treatment and that if IASTM were used in conjunction with other 
treatments, over time in an indicated population that measurable differences the the prior 
mentioned dependent variables would be present. There is a clear disconnect between the way 
IASTM is used clinically verses how it is studied in laboratories. As the basic science, 
mechanisms behind IASTM become clearer through controlled laboratory examination 
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(particularly in animal models) researchers will be able to begin exploring the effects of IASTM 
as part of a larger subject treatment plan. 
 
5.2 The need for IASTM research in indicated populations 
 One possible reason our findings for MTS, PROM, MVC-PT, myokine expression, 
perception of functional ability as measured by the PFAQ, muscle quality (echo intensity), 
pennation angle or hip ROM were statistically insignificant could be due to the healthy 
populations that were used (Kim et al., 2017). With the exception of our third investigation, 
which used subjects who were classified as “hamstrings restricted” (Halbertsma & Goeken, 
1994), all participants in these research investigations were healthy, college-aged students. 
Generally, the investigations, which found clear benefit from IASTM (Davidson et al., 1997; 
Gehlsen et al., 1999) were carried out in animal models utilizing injured rodents including 
collagenase induced achilles tendinopathy. It makes sense from both a physiological and 
statistical point of view that treating an injured population with clear physiological deficits in 
the variables of interest would be more likely to yield statistically significant, positive outcomes. 
Our study designs in the first two investigations used IASTM as more of a training tool then a 
rehabilitation tool. Our data from these investigations indicate that IASTM has little efficacy as a 
training tool to increase ROM or cause detectable increases in strength measures in 
asymptomatic populations.  
 The third study utilized one group of subjects who were suffering from short hamstrings 
syndrome as determined by unilateral straight leg raise. Therefore, these subjects did have a 
positive indication for receiving the IASTM treatment. Of these restricted subjects, none 
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reported any symptoms that are often associated with shortened hamstrings and/or other 
posterior kinetic chain restriction (low back pain, sciatica etc.). These participants were likely 
asymptomatic because they were young and active. Irrespective of symptoms, we would expect 
that the biomechanical and possible genetic predispositions that lead to these subjects having 
chronically shortened hamstrings had also caused alterations in pennation angle. This 
hypothesis that baseline pennation angle in the hamstrings restriction group would differ from 
that of the healthy population proved to be a faulty hypothesis. In addition to there being no 
differences in baseline pennation angle between the two groups there was no group interaction 
for any of the ultrasound data in study three.  
 As previously mentioned, prior to our third investigation we suspected that the primary 
reason we were finding no physiological changes in skeletal muscle performance following 
IASTM was due to the fact that we were carrying out our investigations in healthy, 
asymptomatic populations.  The fact that we saw no detectable changes in pennation angle 
following IASTM within our hamstrings restricted population causes us to wonder if our lab is 
using sensitive enough measurements to detect change. Further, these results suggest that 
future research should include symptomatic subjects who have recently suffered acute injury or 
those who are suffering from chronic pathologies (i.e. tendonitis, tendinosis).   
 The fact that there were no changes in hamstrings ROM following IASTM was surprising 
as it has been demonstrated that massage can alter hamstrings ROM even in healthy, 
asymptomatic populations who are not suffering from short-hamstrings syndrome (Diana 
Hopper et al., 2005; D Hopper et al., 2005). It is possible that the use of manual goniometry 
rather than an isokinetic dynamometer added variance to these ROM values. Manual 
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goniometry was used, as it was more cost effective than having a custom lever arm built and 
much more efficient from a time per visit perspective. Due to time restraints associated 
collaborators this method seemed most appropriate. 
 
5.3 Time course of proposed benefits of IASTM  
 One research question that has stumped both researchers (Crawford et al., 2014) and 
clinicians alike is the question of when to use IASTM following damage to skeletal muscle. This 
is a complex question as many variables including, training status, type of damage and stage of 
healing come into play. The data at hand does not speak to this research question, as it was not 
carried out following any training or injury event. However, prior research has suggested that 
following eccentric loading-induced muscle damage starting IASTM treatments immediately 
following the damaging event or -24 hours post were both equally efficacious in returning 
muscle/tendon stiffness to pre-damage values (Crawford et al., 2014).   
  
5.3.2 IASTM Treatment during Acute Injury Phase 
A common debate amongst clinicians is if IASTM treatments are appropriate during the 
acute injury phase of healing in damaged/pathologic tissue. It has been anecdotally reported 
that many clinicians avoid IASTM during the acute injury phase as it may cause further 
inflammation and damage. Conversely, it has also been anecdotally reported that clinicians use 
IASTM tools to help facilitate lymphatic reabsorption of inflammatory secretions by use of 
superficial strokes towards the heart. Data generated during investigation one demonstrated 
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that IASTM does not initiate inflammation signaling in healthy, asymptomatic tissue (Vardiman 
et al., 2015). However, in the presence of positive indications for IASTM evidence has 
demonstrated that soft tissue mobilization may have the ability to initiate inflammation at the 
cellular level (Davidson et al., 1997; Gehlsen et al., 1999; Hammer, 2008). This ultimately leads 
to increased fibronectin and fibroblast proliferation and aids in healing of degenerate tissue 
(Hammer, 2008).  
 In addition to IASTM potentially causing localized cellular inflammation, it appears 
IASTM and other forms of soft tissue mobilization more than likely elicit localized and possibly 
systemic increases in blood flow (Franklin et al., 2014). If IASTM is efficacious it is likely through 
an inflammation-mediated pathway. With this in mind it seems prudent to not further 
exacerbate inflammation in already inflamed tissue. Especially considering IASTM has been 
shown to be efficacious in respect to fibroblast proliferation irrespective of time administered 
post injury (Crawford et al., 2014). 
 Though it is likely unwise to elicit further inflammatory response using IASTM 
immediately following acute muskulo-skeletal injury, there is a growing body of literature 
suggesting that it may be similarly unwise to use therapeutic modalities and compression to 
reduce inflammation (Fredericson, Moore, Guillet, & Beaulieu, 2005; Kim et al., 2017; Molloy, 
Wang, & Murrell, 2003). Restriction of the localized inflammatory response has been suggested 
to “disorganize and weaken” the soft tissue structure (Fredericson et al., 2005). However, the 
more compelling argument not to combat inflammation following an acute injury stems from 
the reports that localized inflammation leads to secretion of growth factors, which aid in the 
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facilitation of healing through fibroblast proliferation and subsequent collagen synthesis. 
(Molloy et al., 2003).  
5.4 Dosage Recommendations 
 As previously stated, one variable that makes exploring the efficacy of IASTM difficult is 
the fact that there are no commercially available devices that quantify load and volume 
administered during IASTM treatments. However, using consistent, uniformed pressure is not a 
problem unique to researchers. Though no research has compared and contrasted forces 
administered between clinicians during IASTM it is likely highly variable. The purpose behind 
investigation two was to help clarify the effects of different pressure forces on muscle 
performance in human subjects.  Literature review revealed that there is a dose/response main 
effect for pressure administered for fibro-blast proliferation and likely down-stream collagen 
synthesis (Gehlsen et al., 1999) (Table 1). Exploring this pressure dose/response relationship 




Table 1: Dosage Parameters: Comparison of clinical animal/human model pressure 
administration 
 
Author, Year Model Summary Pressure Force  Administered Outcome 
(Gehlsen et al., 1999) Collagenase induced 
Achilles tendonitis rat 
model (n=30) 
Light IASTM= (.5 N/𝑚𝑚𝑚𝑚2) 
Medium IASTM= (1 N/𝑚𝑚𝑚𝑚2) 





(M. T. Loghmani & 
Warden, 2009) 
Bilateral torn MCL rat 
model (n=51) 






(M. Loghmani & 
Warden, 2013) 
Bilateral torn MCL rat 
model (n=30) 




(Davidson et al., 
1997) 
Collagenase induced 
achilles tendonitis rat 
model (n=20) 




(Vardiman et al., 
2015) 
Human Subjects, 
controlled trial (n=11) 
N/𝑚𝑚𝑚𝑚2 equivalent is estimated 
at 1.0 
No changes in 
ROM or IL-6 
expression 
(p<.05) 
Ohio State Group Rabbit tibialis 
anterior, eccentric 
loading (n= varies 












Our second research investigation explored dose response using a “medium pressure” 
group (1.03 N/𝑚𝑚𝑚𝑚2) (Gehlsen et al., 1999) and a “very light” group. Neither of our groups 
demonstrated statistically significant differences from the control or sham group so these data 
are not helpful in making dosage parameter recommendations.  Based on literature review, the 
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most desirable load during an IASTM treatment is 1.0 N/𝑚𝑚𝑚𝑚2 performed over the course of 
three minutes with strokes running both proximal to distal as well as distal to proximal (Gehlsen 
et al., 1999). Further, It would appear that in instances of tendinopathy the tendon should be 
scraped primarily as opposed to the muscle belly (Gehlsen et al., 1999). 
As previously stated most clinicians do not have the equipment or expertise available to 
quantify and control for pressure administered during an IASTM treatment. During our second 
investigation we administered treatments that corresponded with the ideal pressure force of 
1.0 N/𝑚𝑚𝑚𝑚2(Gehlsen et al., 1999). Anecdotally, we observed no bruising during subsequent 
IASTM follow-up visits, which suggests that the most efficacious IASTM treatments will more 
than likely not elicit bruising.  
5.5 Future Research Recommendations 
 Future research investigations should continue to explore the effects of dosage 
parameters, treatment frequency and how IASTM responses are moderated when used as one 
part of a holistic rehabilitation plan. Further, future research should use controlled, clinical 
trials featuring symptomatic populations. Of particular interest should be patients suffering 
from acute muscle tears and strains, those with chronic tendinopathies including tendinitis and 
tendinosis and those recovering from post-surgical tendon repair. Though these populations 
have been explored in rodents using collagenase injections to induce tendinopathy (Davidson et 
al., 1997; Gehlsen et al., 1999) there are no controlled, clinical trials who have investigated 
these populations in humans.  
One issue that presents its self when conducting in-vivo experiments in injured and 
pathologically degenerate muscle tissue in humans is the difficulty of correctly quantifying the 
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severity of an injury for between-subjects comparison. For this reason, the most practical study 
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Documents used in all studies 
Health History Questionnaire  
 
APPLIED PHYSIOLOGY LABORATORY 
UNIVERSITY OF KANSAS 
 
MEDICAL HISTORY FORM 
 
NAME:   DATE:   
 
AGE:   HEIGHT:   WEIGHT:    
 
A.  Have you ever experienced any of the following conditions or procedures? 
 
1.   Myocardial Infarction YES NO 
2.  Angiography YES NO 
3.   Coronary Surgery YES NO 
4.   Chest Discomfort YES NO 
5.   Hypertension (high blood pressure) YES NO 
6.   Hypotension (low blood pressure) YES NO 
Systolic ≤ 100mmHg or Diastolic ≤ 60mmHg   
7.   Shortness of breath upon light exertion YES NO 
8.   Dizziness upon light exertion YES NO 
9.   Pulmonary disease YES NO 
10. Heart palpitation YES NO 
11. Heart murmur YES NO 
12. Diabetes YES NO 
If “YES”, Type I or Type II   
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13. Extremity discomfort YES NO 
14. Claudication (circulation problems cause leg pain) YES NO 
15. Peptic Ulcers YES NO 
16. Metal implants (including pins) YES NO 
 
Does anyone in your family have a history of cardiovascular disease? YES
 NO If “YES”, who?    
 
 
B.  Do you smoke? YES NO 
C.  Are you currently using any anti-asthmatic medications? YES NO 
D.  Are you currently using any anti-hypertensive medications? YES NO 
E.   Are you currently taking any anti-inflammatory medications? YES NO 
F.   Are you currently taking any blood thinners (i.e.: Coumadin, aspirin) YES NO 
G.  Are you currently taking any other kind of medication? YES NO 









H. Are you allergic to idodine (Betadine, tincture of Iodine)? YES NO 
 
I. Have you ever been treated for a heat related illness 
(heat exhaustion, heat stroke)? YES NO 
 
J. What is your current Cholesterol level? (If known)    
 
K. What is your current Blood-Pressure? (must be measured by APL staff)    
 




Unhealed Fractures YES NO  
Thrombophlebitis (blood clots) YES NO  
Recent Surgery YES NO  
Recent Uncontrolled Bruising YES NO  
Osteomyelitis (acute or chronic bone infection) YES NO  
Myositis Ossificans (hardened scarring in muscle tissue of the thigh) YES NO 
    
M. Do you currently or have you been recently diagnosed with any of the following conditions? 
 
Varicose Veins YES NO 
Burn Scars YES NO 
Rheumatoid Arthritis YES NO 
Acute Inflammatory Conditions YES NO 
Pregnancy YES NO 
Osteoporosis YES NO 
 
 




Perception of Functional Abilities Questionnaire  
 
Default Question Block 
 
In the following questionnaire, you will be asked to rate your overall physical health, muscular 
flexibility, and muscular strength.  You will also be asked to rate these relative to a affected body part.  
You will also be asked to rate your pain and ability to perform sport specific activities or activities of 
daily living. 
 
Please indicate if this is the first or second time you have completed this survey 
 
Please rate the following by circling the most appropriate number  
 
   Poor Good Excellent 
 
Please rate the following by circling the most appropriate number 
 















          
100 
 
Please rate the following by circling the most appropriate number 
 
   Poor Good Excellent 
 
Please rate the following by circling the most appropriate number 
 
   Poor Good Excellent 
 
Please rate the following by circling the most appropriate number 
 
   Poor Good Excellent 
 
Please rate the following (note the different scale form the one used previously) by circling the most 
appropriate number 
 
   None Debilitating 
























Please rate the following (note the different scale form the one used previously) by circling the most 
appropriate number 
 
   No effect Not able to perform 
 
Please rate the following (note the different scale form the one used previously) by circling the most 
appropriate number 
 
   No effect Not able to perform 
 
   No effect Not able to perform 
   0 1 2 3 4 5 6 7 8 10 
of daily living? 

























Regular physical activity is fun and healthy, and increasingly more people are starting to become more active every day. 
Being more active is very safe for most people. However, some people should check with their doctor before they start 
becoming much more physically active. 
If you are planning to become much more physically active than you are now, start by answering the seven questions in 
the box below. If you are between the ages of 15 and 69, the PAR-Q will tell you if you should check with your doctor 
before you star t. If you are over 69 years of age, and you are not used to being very active, check with your doctor. 
Common sense is your best guide when you answer these questions. Please read the questions carefully and answer each one 
honestly: check YES or NO. 
 
 















PLEASE NOTE: If your health changes so that you then answer YES to 
any of the above questions, tell your fitness or health professional. 
Ask whether you should change your physical activity plan. 
DELAY BECOMING MUCH MORE ACTIVE: 
• if you are not feeling well because of a temporary illness such as 
a cold or a fever – wait until you feel better; or 
• if you are or may be pregnant – talk to your doctor before you 
start becoming more active. 
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Informed Use of the PAR-Q: The Canadian Society for Exercise Physiology, Health Canada, and their agents assume no liability for persons who undertake physical activity, and if in doubt 
after completing this questionnaire, consult your doctor prior to physical activity. 
 
 
NAME    
 
SIGNATURE   DATE 
  
 
SIGNATURE OF PARENT  
  











Study 3 Specific Document 
  











Agree Strongly Agree 
1. My leg that received the IASTM treatment feels better 
than it did before treatment. 1 2 3 4 5 
2. My leg that received the therapeutic ultrasound 
treatment feels better than it did before treatment. 1 2 3 4 5 
3. My leg that received the IASTM treatment feels more 
flexible following treatment than it did before treatment. 1 2 3 4 5 
4. My leg that received the therapeutic ultrasound 
treatment feels more flexible following treatment than it 
did before treatment. 




Data Used in Statistical Analysis 
  
Investigation one: Western Immuno-blots 
 
 
Fold Changes in TNF.a Normalized to Tubulin 







1 1 1.714 1.568 1.127 
2 1 1.038 1.195 1.160 
3 1 0.818 0.680 0.699 
4 1 0.418 0.775 0.646 
5 1 0.751 1.080 1.764 
6 1 0.888 0.804 0.595 
7 1 0.636 0.645 0.718 
8 1 0.930 0.649 1.083 
9 1 0.734 0.806 1.012 
10 1 0.365 0.418 0.894 
11 1 0.729 1.151 2.126 
 
 
Fold Changes in IL-6 Normalized to Tubulin 
Subject IL-6 Pre IL-6 24 IL-6 48 IL-6 72 
1 1 0.866 0.917 0.538 
2 1 0.305 0.232 0.286 
3 1 0.445 0.415 0.404 
4 1 1.867 1.591 1.118 
5 1 1.038 1.177 1.577 
6 1 1.050 1.146 1.027 
7 1 0.642 0.722 0.797 
8 1 0.949 1.021 1.193 
9 1 0.940 0.719 1.318 
10 1 0.828 1.950 1.028 











Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post
2-1-D 2.821178 1.576427 11.89271 10.87963 49.10145 41.20717 2.2461 1.952967 54.06972 54.94787 43.13156 43.13883
2-3-D 2.482985 2.710641 37.55169 34.77573 30.25586 30.26538 2.437162 2.278546 37.55169 34.77573 37.02732 37.18489
2-4-N 0.521657 0.550558 10.27658 10.61874 16.3242 16.33521 0.38963 0.45394 10.13496 11.88465 18.32156 18.33219
2-5-D 0.318931 0.510028 12.26015 13.44345 27.05474 27.07239 0.89984 0.760686 21.0784 20.4409 30.02038 30.15443
2-6-N 1.252213 0.946128 43.36631 39.69874 25.72845 25.81309 0.478985 0.090383 52.34943 56.83242 22.98598 22.8492
2-7-D 0.527627 0.55644 13.82284 14.22142 24.04275 24.04291 0.574925 0.695137 15.31428 16.52106 24.03493 24.02042
2-8-N 0.584166 0.523964 15.01284 14.18222 25.07176 25.03949 0.523411 0.398391 16.46153 11.35407 25.89914 26.06176
2-9-D 0.384128 0.479928 11.13783 12.30659 20.94518 20.97701 0.316593 0.281383 7.354236 6.196119 14.84818 14.82063
2-10-N 0.138991 0.194408 4.621034 5.746051 16.88695 16.88341 0.16872 0.175215 5.164603 5.680721 16.9334 16.8775
2-11-D 0.135072 0.196283 11.46654 6.913528 26.05698 26.11458 0.149356 0.254678 11.67334 7.743747 22.97754 23.03486
2-12-N 0.576363 0.518801 11.89271 10.87963 17.86399 17.85983 0.496658 0.46208 11.67557 11.11484 20.93023 20.94333
Mean 0.885756 0.796691 16.66375 15.78779 25.39385 24.69186 0.789216 0.709401 22.07525 21.59019 25.19184 25.21982
SD 0.9259 0.739539 12.11782 10.99732 9.066664 7.103465 0.795384 0.727542 17.66214 18.83122 8.587142 8.629082




4-1-N 2.532903 2.75939 40.2171 41.47736 43.95313 39.25364 2.490712 2.537012 35.18299 34.47552 36.1359 39.25364
4-2-D 0.292787 0.277818 14.37606 13.56938 46.11847 48.91441 0.203563 0.236079 11.86797 12.55537 49.24552 48.91441
4-3-N 3.891787 3.316543 46.78885 48.45302 38.29715 38.00273 2.926806 3.084741 32.67581 37.29745 36.18153 38.00273
4-4-D 0.381389 0.502002 16.57375 13.93262 31.19185 31.16316 0.396759 0.566452 13.10265 20.08976 32.21701 31.16316
4-5-N 0.881546 0.753906 20.79225 19.26939 30.094 30.08564 0.882796 1.109558 18.95623 20.87284 24.98509 30.08564
4-6-D 0.7474 0.736257 13.46596 13.09174 18.83505 18.89016 0.937232 0.856476 15.45212 15.18813 19.80871 18.89016
4-7-N 1.434177 1.624385 33.50951 32.12365 28.90189 28.9389 2.013333 1.602279 31.20865 25.86843 29.99496 28.9389
4-8-D 0.182532 0.468782 6.422307 8.52671 14.8421 14.88445 0.297049 0.421355 9.378553 11.07497 19.97546 14.88445
4-9-N 6.002048 2.864125 59.4033 57.78249 26.12808 26.1998 4.916738 4.559201 68.21339 69.49049 30.08478 26.1998
4-10-D 0.944059 0.690133 10.69307 8.995461 13.87588 12.87384 0.9334 0.846048 12.63228 11.54248 15.93084 12.87384
4-11-N 0.858539 1.008717 19.05977 20.75127 26.23519 26.15534 0.562882 0.61882 12.54443 13.01177 21.10681 26.15534
4-12-D 0.182965 0.263076 4.009044 4.067839 11.85888 11.8583 0.045443 0.199654 5.79186 6.189264 15.02268 11.8583
Mean 1.527678 1.272095 23.77591 23.50341 27.52764 27.26836 1.383893 1.386473 22.25058 23.13804 27.55744 27.26836
SD 1.781202 1.0979 17.33275 17.4033 11.38297 11.37753 1.450728 1.344869 17.42677 17.43671 10.04731 11.37753
Treatment Leg Control Leg
MTS Passive Torque ROM MTS Passive Torque ROM
3-1-D 0.171512 0.213558 4.657364 4.764066 14.86452 14.83746 0.302736 0.325026 9.646121 10.82118 25.0637 14.83746
3-2-N 0.374946 0.436189 12.94816 13.72957 27.0666 27.05714 0.302736 0.325026 9.646121 10.82118 25.0637 27.05714
3-3-D 0.174083 0.129398 6.694918 5.827707 23.16009 23.1659 0.239663 0.234606 6.788771 6.625407 17.98572 23.1659
3-4-N 1.064236 0.919075 16.65584 15.91354 18.95675 18.98182 1.379207 1.197092 21.64088 20.71909 23.14895 18.98182
3-5-D 1.415144 1.457078 10.71205 11.88601 8.740042 8.611056 2.112794 1.765946 11.50996 11.45904 8.744107 8.611056
3-6-N 3.263294 2.202749 67.93216 66.2166 33.275 33.30527 3.08016 3.807906 72.55964 67.68129 38.21157 33.30527
3-7-D 0.553747 3.025446 11.60595 23.59997 18.96918 18.98459 0.527055 0.680671 11.41829 13.20111 18.97537 18.98459
3-8-N 3.738518 1.767131 26.58878 24.38284 16.6228 16.465 4.108902 1.803206 43.64477 34.82336 36.29186 16.465
3-9-D 1.533463 1.454649 42.48809 39.9586 17.93482 17.9651 2.571299 3.229047 56.88151 44.26156 16.06305 17.9651
Mean 1.365438 1.289475 22.2537 22.91988 19.95442 19.93037 1.62495 1.485392 27.08178 24.49036 23.28311 19.93037
SD 1.315271 0.968237 20.70919 19.50833 7.133646 7.175282 1.418737 1.303945 24.41268 20.51665 9.411272 7.175282
















Subject Group Initial Stretch M-PROM Quality BF-CSA relaxed 90 Mid Max
2 1 130 150 65.932 3.804 9.436 6.345 6.114 5.463
3 2 165 170 51.576 6.173 6.741 6.482 5.668 3.693
4 1 154 165 66.482 5.088 11.025 10.285 9.474 6.603
5 2 155 169 47.126 7.417 11.583 7.728 6.171 4.281
6 1 124 148 46.675 9.826 10.254 9.452 7.562 6.284
7 2 153 175 55.213 7.57 5.762 3.254 6.123 3.352
9 2 154 165 57.287 7.329 3.748 14.326 7.829 5.265
10 1 130 155 44.743 10.68 7.342 7.132 6.983 5.432
11 1 122 143 67.652 8.354 7.44 5.481 5.634 4.842
12 2 138 160 54.467 8.547 7.34 7.542 6.843 5.632
13 2 160 175 76.841 6.787 7.904 9.684 8.836 9.84
15 2 170 178 56.876 6.934 7.135 5.635 4.962 3.725
16 1 132 150 53.172 6.865 6.238 7.665 5.892 3.965
17 2 126 150 60.235 9.662 2 10.003 7.436 5.836
18 1 120 143 63.396 8.117 3 11.642 7.865 6.34
19 2 165 170 60.634 9.253 4 3.254 6.123 3.352
20 1 123 150 80.409 8.241 5 6.117 6.442 4.395
Stretches Pennation Angle
Pre IASTM
Subject Group Stretches M-PROM Quality BF-CSA relaxed 90 Mid Max
2 1 119 138 66.071 3.981 9.453 5.364 7.364 6.364
3 2 165 175 58.385 6.482 7.529 7.263 5.609 3.798
4 1 160 168 63.346 5.194 9.015 8.461 5.054 5.969
5 2 160 175 45.712 7.517 16.741 13.539 11.032 9.267
6 1 128 150 45.759 9.832 9.532 7.481 6.235 5.584
7 2 156 176 54.8 6.529 4.023 3.743 3.092 3.455
9 2 160 168 57.834 7.439 3.451 7.824 5.421 3.345
10 1 128 150 47.58 10.267 6.832 5.945 4.321 3.245
11 1 121 146 68.659 8.343 7.874 8.843 5.241 3.432
12 2 135 160 56.477 8.496 9.635 8.324 8.127 7.943
13 2 161 175 6.787 6.77 14.265 12.804 10.135 9.351
15 2 174 180 56.876 6.934 8.346 7.362 5.314 4.821
16 1 122 150 53.983 6.683 7.238 7.784 6.143 4.562
17 2 130 150 66.325 9.612 9.635 11.492 8.961 6.642
18 1 113 135 65.386 8.342 10.955 13.941 9.145 7.265
19 2 155 175 53.983 6.683 4.023 3.743 3.092 3.455
20 1 125 150 79.306 7.953 8.752 6.351 6.423 5.843
Post IASTM










Subject Group Initial Stretch M-PROM Quality BF-CSA relaxed 90 Mid Max
2 1 119 139 68.932 3.874 9.806 6.555 6.136 5.406
3 2 170 179 61.496 6.475 6.343 6.453 5.668 3.693
4 1 160 170 62.687 5.142 11.196 10.496 9.575 6.708
5 2 152 168 46.826 7.328 9.475 5.826 4.978 3.283
6 1 124 142 50.963 9.431 9.784 7.453 7.021 4.21
7 2 142 164 51.082 6.937 3.836 3.844 3.684 2.845
9 2 160 170 47.881 7.189 4.392 10.265 7.803 3.076
10 1 128 145 43.841 10.68 6.561 10.305 7.321 5.876
11 1 128 145 58.105 6.284 6.861 8.311 7.035 5.698
12 2 145 165 57.687 8.354 6.818 6.608 6.308 6.503
13 2 161 175 72.778 6.589 6.525 6.466 6.349 3.195
15 2 150 175 54.468 6.669 6.376 5.376 5.083 3.501
16 1 122 150 51.62 6.891 7.453 7.384 5.432 3.846
17 2 130 155 60.785 9.786 10.757 9.754 7.824 5.943
18 1 113 140 72.384 8.462 11.924 9.754 7.865 6.862
19 2 150 178 51.62 6.891 3.836 3.844 3.684 2.845
20 1 140 152 81.942 8.114 6.354 6.495 6.624 4.386
Stretches Longitudinal Pennation Angle
Pre Sham
Subject Group Initial Stretch M-PROM Quality BF-CSA relaxed 90 Mid Max
2 1 119 138 68.879 3.884 9.591 5.593 7.275 6.36
3 2 170 179 60.492 6.381 7.925 7.326 5.634 3.798
4 1 165 170 62.641 4.938 9.207 8.364 5.592 5.875
5 2 148 172 44.816 7.683 9.869 6.29 5.343 4.191
6 1 134 146 48.661 9.596 11.872 9.395 5.986 4.824
7 2 148 172 52.745 7.248 3.641 3.916 3.156 3.964
9 2 165 170 47.771 6.963 4.151 8.871 4.153 3.482
10 1 128 145 46.382 10.211 8.576 8.376 7.873 6.432
11 1 122 143 62.341 6.109 7.636 6.667 5.076 4.426
12 2 121 146 61.385 8.197 9.321 7.521 5.321 3.212
13 2 167 175 74.229 6.734 7.635 5.705 5.686 3.621
15 2 170 175 52.586 6.623 10.897 5.934 3.875 8.395
16 1 128 145 53.621 6.954 9.235 7.757 6.327 5.324
17 2 140 155 60.364 9.386 10.345 10.623 7.635 4.986
18 1 120 140 70.653 8.216 11.364 9.649 7.641 6.518
19 2 150 175 52.514 6.427 3.641 3.916 3.156 3.964
20 1 140 152 82.006 7.742 6.348 6.442 5.624 4.935
Pennation Angle
Post Sham
Stretches Longitudinal
